FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Leonhard, S
   Barreira, A
   Van Doorn, P
   Amorelli, M
   Araujo, W
   Gondim, FDA
   Brito, M
   Tan, CY
   Cornblath, D
   Dourado, ME
   Fonseca, B
   Souza, DGB
   Islam, Z
   Maciel, E
   Marques, W
   Matos, L
   Mohammad, QD
   Osorio, L
   Pardo, C
   Parra, B
   Reisin, R
   Resende, G
   Dos Santos, D
   Sejvar, J
   Shahrizaila, N
   Mendonca, HS
   Solomon, T
   Thirugnanam, U
   Willison, H
   Jacobs, B
AF Leonhard, Sonja
   Barreira, Amilton
   Van Doorn, Pieter
   Amorelli, Manuela
   Araujo, Wildo
   Aquino Gondim, Francisco De Assis
   Brito, Maria
   Tan Cheng-Yin
   Cornblath, David
   Dourado, Mario Emilio
   Fonseca, Benedito
   Brum Souza, Doralina Guimaraes
   Islam, Zhahirul
   Maciel, Ernane
   Marques, Wilson
   Matos, Luiza
   Mohammad, Quazi Deen
   Osorio, Lyda
   Pardo, Carlos
   Parra, Beatriz
   Reisin, Ricardo
   Resende, Glaucia
   Dos Santos, Diogo
   Sejvar, James
   Shahrizaila, Nortina
   Mendonca, Helena Silva
   Solomon, Tom
   Thirugnanam, Umapathi
   Willison, Hugh
   Jacobs, Bart
TI International Zika virus related Guillain-Barre Syndrome Outcome Study
   (IGOS-Zika): Update of a case-controlled study
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 21-25, 2018
CL Baltimore, MD
SP Peripheral Nerve Soc
DE Inflammatory; Other
C1 [Leonhard, Sonja; Van Doorn, Pieter; Jacobs, Bart] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Barreira, Amilton; Marques, Wilson] Univ Sao Paulo, Med Sch, Dept Neurosci, Ribeirao Preto, Brazil.
   [Amorelli, Manuela] Secretary State Fed Dist, Dept Infect Dis, Brasilia, DF, Brazil.
   [Araujo, Wildo] Univ Brasilia, Ceilandia Fac, Dept Epidemiol, Brasilia, DF, Brazil.
   [Aquino Gondim, Francisco De Assis] Hosp Univ Walter Cantidio Fortaleza, Fortaleza, Ceara, Brazil.
   [Brito, Maria] Hosp Restauracao, Recife, PE, Brazil.
   [Tan Cheng-Yin; Shahrizaila, Nortina] Univ Malaya, Dept Neurol, Kuala Lumpur, Malaysia.
   [Cornblath, David; Pardo, Carlos] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.
   [Dourado, Mario Emilio] Hosp Univ Onofre Lopes, Natal, RN, Brazil.
   [Fonseca, Benedito] Med Sch Ribeirao Preto, Dept Virol, Ribeirao Preto, Brazil.
   [Brum Souza, Doralina Guimaraes] Hosp Clin Fac Med Botucatu, Botucatu, SP, Brazil.
   [Islam, Zhahirul] Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh.
   [Maciel, Ernane; Matos, Luiza] Hosp Base Dist Fed, Brasilia, DF, Brazil.
   [Mohammad, Quazi Deen] Inst Neurosci & Hosp NINS, Dhaka, Bangladesh.
   [Osorio, Lyda; Parra, Beatriz] Univ Valle, Cali, Colombia.
   [Reisin, Ricardo] Hosp Britanico, Buenas Aires, Argentina.
   [Resende, Glaucia] Hosp Municipal Odilon Behrens MG, Belo Horizonte, MG, Brazil.
   [Dos Santos, Diogo] Hosp Clin Univ Fed Oberlandia, Oberlandia, Brazil.
   [Sejvar, James] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [Mendonca, Helena Silva] Univ Fed Goias, Goiania, Go, Brazil.
   [Solomon, Tom] Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Thirugnanam, Umapathi] Natl Neurosci Inst, Singapore, Singapore.
   [Willison, Hugh] Univ Glasgow, Dept Neurol, Glasgow, Lanark, Scotland.
RI Marques, Wilson/G-4240-2012; Tan, Cheng-Yin/AAX-1763-2020; Araujo, Wildo
   Navegantes/AAD-9163-2020; Pardo, Carlos A./A-5192-2008
OI Marques, Wilson/0000-0002-4589-2749; Araujo, Wildo
   Navegantes/0000-0002-6856-4094; Pardo, Carlos A./0000-0002-4128-5335
FU European Union's Horizon 2020 research and innovation programme [734584]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No 734584
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD DEC
PY 2018
VL 23
IS 4
BP 321
EP 322
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA HD8EO
UT WOS:000452787700182
DA 2020-11-10
ER

PT J
AU Esposito, DL
   Fonseca, BA
AF Esposito, Danillo
   Fonseca, Benedito
TI INVESTIGATION OF <it>IN VITRO</it> INFECTIVITY OF CHIKUNGUNYA IMMATURE
   VIRUS PARTICLES IN MAMMALIAN AND INSECT CELL LINES
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Esposito, Danillo; Fonseca, Benedito] Univ Sao Paulo, Ribeirao Preto, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 170
BP 53
EP 53
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386602171
DA 2020-11-10
ER

PT J
AU Doltrario, AB
   Silveira, LB
   Silva, RF
   Vilar, FC
   Silva, ACT
   Salomao, MC
   Faiolla, RC
   Del Padua, J
   Fonseca, BA
   Martinez, R
AF Doltrario, Andrea
   Silveira, Lude
   Silva, Rafael
   Vilar, Fernando
   Silva, Anna
   Salomao, Mariana
   Faiolla, Rivian
   Del Padua, Joel
   Fonseca, Benedito
   Martinez, Roberto
TI CRACK LUNG MIMICKING MILIARY TUBERCULOSIS AND FUNGAL DISEASES IN A
   HIV-INFECTED PATIENT
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Doltrario, Andrea; Silveira, Lude; Silva, Rafael; Vilar, Fernando; Silva, Anna; Salomao, Mariana; Faiolla, Rivian; Del Padua, Joel; Fonseca, Benedito; Martinez, Roberto] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Vilar, Fernando Crivelenti/AAK-4233-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1975
BP 621
EP 621
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386605025
DA 2020-11-10
ER

PT J
AU Silveira, LB
   Doltrario, AB
   Silva, RF
   Vilar, FC
   Silva, ACT
   Salomao, MC
   Faiolla, RC
   Fabro, AT
   Fonseca, BA
   Martinez, R
AF Silveira, Lude
   Doltrario, Andrea
   Silva, Rafael
   Vilar, Fernando
   Silva, Anna
   Salomao, Mariana
   Faiolla, Rivian
   Fabro, Alexandre
   Fonseca, Benedito
   Martinez, Roberto
TI SUCCESSFUL TREATMENT OF DISSEMINATED STRONGYLOIDIASIS WITH SUBCUTANEOUS
   IVERMECTIN
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 67th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTHM)
CY OCT 28-NOV 01, 2018
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg, Bill & Melinda Gates Fdn, Takeda Pharmaceut Int AG, Novartis Social Business, Celgene Corp, Techlab Inc, Indiana Univ, Sch Med, B EI Resources, Sanofi Pasteur, Welcome, PLOS, Elsevier
C1 [Silveira, Lude; Doltrario, Andrea; Silva, Rafael; Vilar, Fernando; Silva, Anna; Salomao, Mariana; Faiolla, Rivian; Fabro, Alexandre; Fonseca, Benedito; Martinez, Roberto] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Vilar, Fernando Crivelenti/AAK-4233-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2018
VL 99
IS 4
SU S
MA 1976
BP 621
EP 621
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA HP0WF
UT WOS:000461386605026
DA 2020-11-10
ER

PT J
AU Moraes, FM
   Esposito, DL
   Klein, TM
   Fonseca, BA
AF Moraes, Flavia M.
   Esposito, Danillo L.
   Klein, Taline M.
   Fonseca, Benedito A.
TI EVALUATION OF SELECTED REAL-TIME RT-PCR PROTOCOLS AIMING AT THE BEST
   POSSIBLE MOLECULAR DIAGNOSIS OF ZIKA VIRUS INFECTIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Moraes, Flavia M.; Esposito, Danillo L.; Klein, Taline M.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 747
BP 235
EP 236
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502270
DA 2020-11-10
ER

PT J
AU Torres, FP
   Esposito, DL
   Klein, TM
   Moraes, FM
   Persona, MR
   Fonseca, BA
AF Torres, Fernanda P.
   Esposito, Danillo L.
   Klein, Taline M.
   Moraes, Flavia M.
   Persona, Michelli R.
   Fonseca, Benedito A.
TI DEFINING THE CLINICAL MANIFESTATIONS OF ZIKA AND DENGUE PATIENTS
   ATTENDED IN RIBEIRAO PRETO, BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Torres, Fernanda P.; Esposito, Danillo L.; Klein, Taline M.; Moraes, Flavia M.; Persona, Michelli R.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1366
BP 429
EP 429
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502889
DA 2020-11-10
ER

PT J
AU Esposito, DL
   Moraes, FM
   Klein, TM
   Persona, MR
   Ribeiro, BS
   Molla, VC
   Frade, MAC
   Fonseca, BA
AF Esposito, Danillo L.
   Moraes, Flavia M.
   Klein, Taline M.
   Persona, Michelli R.
   Ribeiro, Beatriz S.
   Molla, Vinicius C.
   Frade, Marco Andrey C.
   Fonseca, Benedito A.
TI ZIKA VIRUS INFECTIONS: PAYING ATTENTION TO ATYPICAL PRESENTATIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 13-16, 2016
CL Atlanta, GA
SP Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs
C1 [Esposito, Danillo L.; Moraes, Flavia M.; Klein, Taline M.; Persona, Michelli R.; Ribeiro, Beatriz S.; Molla, Vinicius C.; Frade, Marco Andrey C.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI FRADE, MARCO ANDREY/AAB-5450-2020; Frade, Marco A C/G-1165-2012;
   Esposito, Danillo L.A./N-9261-2017
OI FRADE, MARCO ANDREY/0000-0003-2700-5971; Frade, Marco A
   C/0000-0003-2700-5971; Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2017
VL 95
IS 5
SU S
MA 1383
BP 435
EP 435
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FJ6FS
UT WOS:000412851502906
DA 2020-11-10
ER

PT J
AU Silva, JR
   Lopes, AH
   Talbot, J
   Cecilio, NT
   Rossato, MF
   Silva, RL
   Souza, GR
   Silva, CR
   Lucas, G
   Fonseca, BA
   Arruda, E
   Alves, JC
   Cunha, FQ
   Cunha, TM
AF Silva, Jaqueline R.
   Lopes, Alexandre H.
   Talbot, Jhimmy
   Cecilio, Nerry T.
   Rossato, Mateus F.
   Silva, Rangel L.
   Souza, Guilherme R.
   Silva, Cassia R.
   Lucas, Guilherme
   Fonseca, Benedito A.
   Arruda, Eurico
   Alves-Filho, Jose C.
   Cunha, Fernando Q.
   Cunha, Thiago M.
TI Neuroimmune-Glia Interactions in the Sensory Ganglia Account for the
   Development of Acute Herpetic Neuralgia
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE glial cells; herpes; inflammation; pain
ID SIMPLEX-VIRUS TYPE-1; DORSAL-ROOT GANGLIA; TUMOR-NECROSIS-FACTOR;
   RECTIFYING POTASSIUM CURRENTS; TRIGEMINAL GANGLION; TNF-ALPHA;
   POSTHERPETIC NEURALGIA; NEUROPATHIC PAIN; UP-REGULATION; NERVE INJURY
AB Herpetic neuralgia is the most important symptom of herpes zoster disease, which is caused by Varicella zoster. Nevertheless, the pathophysiological mechanisms involved in herpetic neuralgia are not totally elucidated. Here, we examined the neuroimmune interactions at the sensory ganglia that account for the genesis of herpetic neuralgia using a murine model of Herpes Simplex Virus Type-1 (HSV-1) infection. The cutaneous HSV-1 infection of mice results in the development of a zosteriform-like skin lesion followed by a time-dependent increase in pain-like responses (mechanical allodynia). Leukocytes composed mainly of macrophages and neutrophils infiltrate infected DRGs and account for the development of herpetic neuralgia. Infiltrating leukocytes are responsible for driving the production of TNF, which in turn mediates the development of herpetic neuralgia through downregulation of the inwardly rectifying K+ channel Kir4.1 in satellite glial cells. These results revealed that neuroimmune-glia interactions at the sensory ganglia play a critical role in the genesis of herpetic neuralgia. In conclusion, the present study elucidates novel mechanisms involved in the genesis of acute herpetic pain and open new avenues for its control.
C1 [Silva, Jaqueline R.; Lopes, Alexandre H.; Talbot, Jhimmy; Cecilio, Nerry T.; Rossato, Mateus F.; Silva, Rangel L.; Souza, Guilherme R.; Silva, Cassia R.; Alves-Filho, Jose C.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Dept Pharmacol, Ribeirao Preto Med Sch, BR-14040900 Sao Paulo, Brazil.
   [Silva, Jaqueline R.; Alves-Filho, Jose C.; Cunha, Fernando Q.; Cunha, Thiago M.] Univ Sao Paulo, Grad Program Basic & Appl Immunol, Ribeirao Preto Med Sch, BR-14040900 Sao Paulo, Brazil.
   [Lucas, Guilherme] Univ Sao Paulo, Dept Physiol, Ribeirao Preto Med Sch, BR-14040900 Sao Paulo, Brazil.
   [Fonseca, Benedito A.] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, BR-14040900 Sao Paulo, Brazil.
   [Arruda, Eurico] Univ Sao Paulo, Dept Cellular Biol, Ribeirao Preto Med Sch, BR-14040900 Sao Paulo, Brazil.
RP Cunha, FQ; Cunha, TM (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Pharmacol Dept, Ave Bandeirantes,3900, BR-14040900 Ribeirao Preto, SP, Brazil.
EM fdqcunha@fmrp.usp.br; thicunha@fmrp.usp.br
RI Cunha, Fernando Q/M-3090-2014; Cecilio, Nerry/L-2378-2016; da Silva,
   Cassia Regina/P-3697-2017; Silva, Rangel Leal/G-2009-2016; Cecilio,
   Nerry/L-9927-2017; Cunha, Thiago M/B-7729-2012; Alves-Filho, Jose
   Carlos/B-5814-2008; Lucas, Guilherme/N-8827-2014; Fonseca,
   Benedito/F-3252-2012
OI da Silva, Cassia Regina/0000-0002-1353-2570; Silva, Rangel
   Leal/0000-0002-1322-7808; Cunha, Thiago M/0000-0003-1084-0065;
   Alves-Filho, Jose Carlos/0000-0002-9918-8714; Lucas,
   Guilherme/0000-0002-1656-9571; Cecilio, Nerry
   Tatiana/0000-0001-5465-5238; Cunha, Fernando
   Queiroz/0000-0003-4755-1670; Fonseca, Benedito/0000-0003-3159-5687
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2010/12309-8, 2011/19670-0, 2013/08216-2];
   University of Sao Paulo NAP-DIN [11.1.21625.01.0]; European Union
   Seventh Framework ProgrammeEuropean Union (EU) [HEALTH-F4-2011-281608
   TIMER]; International Association for the Study of Pain (Early Career
   Grant Award); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); CNPqNational Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by the Sao Paulo Research Foundation (FAPESP
   Grant 2010/12309-8, 2011/19670-0 for the thematic project and Grant
   2013/08216-2 to the Center for Research in Inflammatory Disease); the
   University of Sao Paulo NAP-DIN (Grant 11.1.21625.01.0); and the
   European Union Seventh Framework Programme (FP7-2007-2013 Grant
   HEALTH-F4-2011-281608 TIMER); and by the 2011 International Association
   for the Study of Pain (Early Career Grant Award to T.M.C.). J.R.S was a
   recipient of a fellowship from FAPESP and CNPq. We thank Sergio R. Rosa,
   Katia Santos, and Maria Lucia Silva for technical assistance.
CR Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013
   Belzer V, 2010, NEURON GLIA BIOL, V6, P237, DOI 10.1017/S1740925X1100007X
   Carr DJJ, 2006, J GEN VIROL, V87, P489, DOI 10.1099/vir.0.81339-0
   Colleoni M, 2010, BBA-MOL BASIS DIS, V1802, P924, DOI 10.1016/j.bbadis.2009.10.012
   Cunha TM, 2008, J LEUKOCYTE BIOL, V83, P824, DOI 10.1189/jlb.0907654
   Cunha TM, 2004, BRAZ J MED BIOL RES, V37, P401, DOI 10.1590/S0100-879X2004000300018
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   Dubovy P, 2006, CELL MOL NEUROBIOL, V26, P1205, DOI 10.1007/s10571-006-9006-3
   Faust N, 2000, BLOOD, V96, P719
   Freland S, 2000, SCAND J IMMUNOL, V51, P219
   Gan EY, 2013, AM J CLIN DERMATOL, V14, P77, DOI 10.1007/s40257-013-0011-2
   Gilden D, 2011, NEUROPATH APPL NEURO, V37, P441, DOI 10.1111/j.1365-2990.2011.01167.x
   Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674
   Hicks DJ, 2013, J COMP PATHOL, V149, P446, DOI 10.1016/j.jcpa.2013.04.001
   Inglis JJ, 2005, ARTHRITIS RES THER, V7, pR807, DOI 10.1186/ar1743
   Jancalek R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-11
   Javed S, 2011, J MED VIROL, V83, P2051, DOI 10.1002/jmv.22182
   Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005
   Kodukula P, 1999, J IMMUNOL, V162, P2895
   Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100
   Lafaille FG, 2012, NATURE, V491, P769, DOI 10.1038/nature11583
   Lima GK, 2010, AM J PATHOL, V177, P2433, DOI 10.2353/ajpath.2010.100121
   Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338
   MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6
   Nagel MA, 2014, CURR OPIN NEUROL, V27, P356, DOI 10.1097/WCO.0000000000000092
   Njoo C, 2014, JOVE-J VIS EXP, V22, P85
   O'Connor KM, 2013, MED CLIN N AM, V97, P503, DOI 10.1016/j.mcna.2013.02.002
   Ohara PT, 2009, NEUROSCIENTIST, V15, P450, DOI 10.1177/1073858409336094
   Ohtori S, 2004, SPINE, V29, P1082, DOI 10.1097/00007632-200405150-00006
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Opstelten W, 2010, J CLIN VIROL, V48, pS8, DOI 10.1016/S1386-6532(10)70003-2
   Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937
   Patterson CE, 2003, J IMMUNOL, V171, P3102, DOI 10.4049/jimmunol.171.6.3102
   Rittner Heike L, 2007, Curr Rheumatol Rep, V9, P503, DOI 10.1007/s11926-007-0081-3
   Santee Jennifer A, 2002, Am J Clin Dermatol, V3, P517, DOI 10.2165/00128071-200203080-00001
   Sarangi PP, 2007, J VIROL, V81, P11128, DOI 10.1128/JVI.01008-07
   Schafers M, 2008, NEUROSCIENCE, V157, P414, DOI 10.1016/j.neuroscience.2008.08.067
   Schafers M, 2003, NEUROSCI LETT, V347, P179, DOI 10.1016/S0304-3940(03)00695-5
   Shaw SK, 2008, EXP NEUROL, V210, P286, DOI 10.1016/j.expneurol.2007.11.024
   SHIMELD C, 1995, J NEUROIMMUNOL, V61, P7, DOI 10.1016/0165-5728(95)00068-D
   Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009
   Takasaki I, 2000, JPN J PHARMACOL, V83, P319, DOI 10.1254/jjp.83.319
   Takasaki I, 2005, NEUROPHARMACOLOGY, V49, P283, DOI 10.1016/j.neuropharm.2004.12.025
   Takasaki I, 2000, PAIN, V86, P95, DOI 10.1016/S0304-3959(00)00240-2
   Takasaki I, 2002, ANESTHESIOLOGY, V96, P1168, DOI 10.1097/00000542-200205000-00021
   Takeda M, 2015, NEUROSCIENCE, V288, P51, DOI 10.1016/j.neuroscience.2014.12.024
   Takeda M, 2011, PAIN, V152, P2147, DOI 10.1016/j.pain.2011.05.023
   Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005
   Tyring SK, 2007, J AM ACAD DERMATOL, V57, pS136, DOI 10.1016/j.jaad.2007.09.016
   van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13
   Verri WA, 2006, PHARMACOL THERAPEUT, V112, P116, DOI 10.1016/j.pharmthera.2006.04.001
   Vit JP, 2008, J NEUROSCI, V28, P4161, DOI 10.1523/JNEUROSCI.5053-07.2008
   Vit JP, 2006, NEURON GLIA BIOL, V2, P247, DOI 10.1017/S1740925X07000427
   Wilson AC, 2012, TRENDS MICROBIOL, V20, P604, DOI 10.1016/j.tim.2012.08.005
   Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067
NR 55
TC 9
Z9 11
U1 0
U2 6
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 5
PY 2017
VL 37
IS 27
BP 6408
EP 6422
DI 10.1523/JNEUROSCI.2233-16.2017
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA EZ5LT
UT WOS:000404758300004
PM 28576938
OA Green Published, Bronze
DA 2020-11-10
ER

PT J
AU Esposito, DL
   Ferreira, AA
   Moraes, FM
   Persona, MR
   dos Ribeiro, B
   Fabio, SV
   Passos, LMR
   Silva, AAMCE
   Fonseca, BA
AF Esposito, Danillo L.
   Ferreira, Adriana A.
   Moraes, Flavia M.
   Persona, Michelli R.
   dos Ribeiro, Beatriz
   Fabio, Suzi V.
   Passos, Luzia Marcia R.
   Castro e Silva, Ana Alice M.
   Fonseca, Benedito A.
TI ABORTION RATE IS MUCH HIGHER THAN MICROCEPHALY RATE IN ZIKA VIRUS
   INFECTIONS OCCURRING IN THE FIRST TRIMESTER OF PREGNANCY
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 66th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 05-09, 2017
CL Baltimore, MD
SP Amer Soc Trop Med & Hyg
C1 [Esposito, Danillo L.; Ferreira, Adriana A.; Moraes, Flavia M.; Persona, Michelli R.; dos Ribeiro, Beatriz; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [Fabio, Suzi V.; Passos, Luzia Marcia R.; Castro e Silva, Ana Alice M.] Ribeirao Preto Hlth Dept, Ribeirao Preto, SP, Brazil.
RI Esposito, Danillo L.A./N-9261-2017
OI Esposito, Danillo L.A./0000-0002-2755-4471
NR 0
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PY 2017
VL 97
IS 5
SU S
MA 1959
BP 610
EP 610
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FT5TD
UT WOS:000423215204675
DA 2020-11-10
ER

PT J
AU Barreira, AA
   Marques, W
   Marreco, A
   Aquino-Cruz, C
   Esposito, D
   Klein, T
   Jacobs, BC
   Hughes, RAC
   Cornblath, DR
   van Doorn, P
   Gorson, KC
   Hartung, HP
   Willison, HJ
   Kusunoki, S
   Fonseca, B
AF Barreira, A. A.
   Marques, W., Jr.
   Marreco, A.
   Aquino-Cruz, C.
   Esposito, D.
   Klein, T.
   Jacobs, B. C.
   Hughes, R. A. C.
   Cornblath, D. R.
   van Doorn, P.
   Gorson, K. C.
   Hartung, H-P
   Willison, H. J.
   Kusunoki, S.
   Fonseca, B.
TI GUILLAIN-BARRE SYNDROME RELATED TO ZIKA VIRUS INFECTION IN BRAZIL
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Inflammatory Neuropathy Consortium and GBS 100 Centenary Symposium and
   Ceilidh
CY JUN 21-24, 2016
CL Univ Glasgow, Glasgow, SCOTLAND
SP Baxalta, CSL Behring, Grifols, Kedrion S p A, GBS CIDP Fdn Int, Guillain Barre Associated Inflammatory Neuropathies, LFB Biomedicaments, Octapharma, TEVA
HO Univ Glasgow
C1 [Barreira, A. A.] Univ Sao Paulo, Med Sch Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Sch Med, BR-05508 Sao Paulo, Brazil.
   [Marques, W., Jr.; Marreco, A.; Aquino-Cruz, C.; Esposito, D.; Klein, T.; Fonseca, B.] Univ Sao Paulo, Univ Hosp Ribeirao Preto, BR-05508 Sao Paulo, Brazil.
   [Jacobs, B. C.; van Doorn, P.] Erasmus MC, Rotterdam, Netherlands.
   [Hughes, R. A. C.] UCL, Inst Neurol, London, England.
   [Cornblath, D. R.] Johns Hopkins Univ, Baltimore, MD USA.
   [Gorson, K. C.] Tufts Univ, Sch Med, Boston, MA 02111 USA.
   [Hartung, H-P] Univ Dusseldorf, Dusseldorf, Germany.
   [Willison, H. J.] Univ Glasgow, Glasgow, Lanark, Scotland.
   [Kusunoki, S.] Univ Sch Med, Osaka, Japan.
RI Marques, Wilson/G-4240-2012; Gorson, Kenneth/K-7778-2019; Esposito,
   Danillo L.A./N-9261-2017
OI Marques, Wilson/0000-0002-4589-2749; Esposito, Danillo
   L.A./0000-0002-2755-4471
NR 0
TC 0
Z9 0
U1 0
U2 8
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1085-9489
EI 1529-8027
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD SEP
PY 2016
VL 21
IS 3
BP 162
EP 162
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA DW7TY
UT WOS:000383856200020
DA 2020-11-10
ER

PT J
AU dos Santos, AG
   Stucchi, RSB
   Boin, IFSF
   Ataide, E
   Angerami, R
   Cunha, MS
   Souza, RP
   Fonseca, BAL
AF dos Santos, Andrea G.
   Stucchi, Raquel S. B.
   Boin, Ilka F. S. F.
   Ataide, Elaine
   Angerami, Rodrigo
   Cunha, Mariana S.
   Souza, Renato P.
   Fonseca, Benedito A. L.
TI First Reported Case: Zika Virus Infection in a Liver Transplant Patient
SO TRANSPLANTATION
LA English
DT Meeting Abstract
CT 22nd Annual International Congress of the
   International-Liver-Transplantation-Society (ILTS)
CY MAY 04-07, 2016
CL Seoul, SOUTH KOREA
SP Int Liver Transplantat Soc
C1 [dos Santos, Andrea G.; Stucchi, Raquel S. B.; Boin, Ilka F. S. F.; Ataide, Elaine] State Univ Campinas UNICAMP, Fac Med Sci, Unit Liver Transplantat, Campinas, SP, Brazil.
   [Angerami, Rodrigo] State Univ Campinas UNICAMP, Hosp Clin, Sect Hosp Epidemiol, Campinas, SP, Brazil.
   [Cunha, Mariana S.; Souza, Renato P.] Adolfo Lutz Inst, Div Vector Borne Dis, Sao Paulo, Brazil.
   [Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, Div Infect Dis, Dept Internal Med, BR-14049 Ribeirao Preto, SP, Brazil.
RI Angerami, Rodrigo Nogueira/A-8926-2013; Boin, Ilka/M-7184-2019; Boin,
   Ilka FSF/C-7811-2009
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; 
NR 0
TC 0
Z9 0
U1 0
U2 57
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAY
PY 2016
VL 100
SU 5
MA LB-18
BP S166
EP S166
PG 1
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA DN5QY
UT WOS:000377126400278
DA 2020-11-10
ER

PT J
AU Silva, J
   Talbot, J
   Lopes, A
   Franca, R
   Fonseca, B
   Cunha, T
   Cunha, F
AF Silva, Jaqueline
   Talbot, Jhimmy
   Lopes, Alexandre
   Franca, Rafael
   Fonseca, Benedito
   Cunha, Thiago
   Cunha, Fernando
TI Evaluation of immune response in dorsal root ganglion of mice infected
   with Herpes Simplex Virus type 1 (HSV-1)
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 99th Annual Meeting of the American-Association-of-Immunologists
CY MAY 04-08, 2012
CL Boston, MA
SP Amer Assoc Immunol
C1 [Silva, Jaqueline; Fonseca, Benedito; Cunha, Thiago; Cunha, Fernando] Univ Sao Paulo, Dept Biochem & Immunol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil.
   [Talbot, Jhimmy; Lopes, Alexandre; Franca, Rafael] Univ Sao Paulo, Dept Pharmacol, Ribeirao Preto Sch Med, BR-14049 Ribeirao Preto, Brazil.
RI Cunha, Thiago M/B-7729-2012; Cunha, Fernando Q/M-3090-2014
OI Cunha, Thiago M/0000-0003-1084-0065; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2012
VL 188
PG 1
WC Immunology
SC Immunology
GA 950OX
UT WOS:000304659700593
DA 2020-11-10
ER

PT J
AU Bonfa, A
   Saito, RSN
   Franca, RFO
   Fonseca, BAL
   Petri, DFS
AF Bonfa, Alfredo
   Saito, Rafael S. N.
   Franca, Rafael F. O.
   Fonseca, Benedito A. L.
   Petri, Denise F. S.
TI Poly(ethylene glycol) decorated poly(methylmethacrylate) nanoparticles
   for protein adsorption
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Poly(ethylene)glycol; Nanoparticles; BSA; Concanavalin A; Dengue virus;
   Adsorption
ID CONCANAVALIN-A; THIN-FILMS; ALBUMIN; BINDING; PARTICLES; BEHAVIOR; PH
AB Poly(ethylene glycol) decorated poly( methyl methacrylate) particles were synthesized by means of emulsion polymerization using poly(ethylene glycol) sorbitan monolaurate (Tween-20) as surfactant. PMMA/PEG particles presented mean diameter (195 +/- 15) nm, indicating narrow size distribution. The adsorption behavior of bovine serum albumin (BSA) and concanavalin A (ConA) onto PMMA/PEG particles was investigated by means of spectrophotometry. Adsorption isotherms obtained for BSA onto PMMA/PEG particles fitted well sigmoidal function, which is typical for multilayer adsorption. Con A adsorbed irreversibly onto PMMA/PEG particles. The efficiency of ConA covered particles to induce dengue virus quick agglutination was evaluated. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Bonfa, Alfredo; Saito, Rafael S. N.; Petri, Denise F. S.] Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
   [Franca, Rafael F. O.] Univ Sao Paulo, Fac Med Ribeirao Preto, Programa Pos Grad Imunol Basica & Aplicada, Ribeirao Preto, Brazil.
   [Fonseca, Benedito A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, Brazil.
RP Petri, DFS (corresponding author), Univ Sao Paulo, Inst Quim, POB 26077, BR-05513970 Sao Paulo, Brazil.
EM dfsp@iq.usp.br
RI PETRI, DENISE/H-5004-2012; Petri, Denise/L-5084-2019; Fonseca,
   Benedito/F-3252-2012
OI PETRI, DENISE/0000-0003-4814-8357; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Fonseca, Benedito/0000-0003-3159-5687
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)
FX Authors gratefully acknowledge CNPq and FAPESP for financial support.
CR Adamson A. W., 1997, PHYS CHEM SURFACES
   Almeida AT, 2002, LANGMUIR, V18, P6914, DOI 10.1021/la0202982
   Amim J, 2009, MAT SCI ENG C-BIO S, V29, P420, DOI 10.1016/j.msec.2008.08.018
   Bock G., 2006, NEW TREATMENT STRATE
   BREWER CF, 1983, BIOCHEMISTRY-US, V22, P3691, DOI 10.1021/bi00284a024
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   Castro LBR, 2005, J NANOSCI NANOTECHNO, V5, P2063, DOI 10.1166/jnn.2005.501
   Castro LBR, 2004, IND ENG CHEM RES, V43, P7774, DOI 10.1021/ie0495271
   Chern CS, 1999, COLLOID POLYM SCI, V277, P528, DOI 10.1007/s003960050420
   de Moura MR, 2009, MAT SCI ENG C-MATER, V29, P2319, DOI 10.1016/j.msec.2009.05.022
   DOSERPO APV, 1991, J BIOM MAT RES, V46, P376
   Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3
   Fuller EL, 2007, MICROPOR MESOPOR MAT, V98, P102, DOI 10.1016/j.micromeso.2006.08.019
   Giacomelli CE, 2001, J COLLOID INTERF SCI, V233, P234, DOI 10.1006/jcis.2000.7219
   Gilbert R. G., 1995, EMULSION POLYM MECH
   Goubko CA, 2009, MAT SCI ENG C-MATER, V29, P1855, DOI 10.1016/j.msec.2009.02.016
   Jelinek R, 2004, CHEM REV, V104, P5987, DOI 10.1021/cr0300284
   Jo TA, 2009, MAT SCI ENG C-BIO S, V29, P631, DOI 10.1016/j.msec.2008.10.035
   Kim HR, 2007, ELECTROPHORESIS, V28, P2252, DOI 10.1002/elps.200600694
   LOVGREN U, 1995, J CHROMATOGR B, V672, P33, DOI 10.1016/0378-4347(95)00198-R
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   Pancera SM, 2006, J PHYS CHEM B, V110, P2674, DOI 10.1021/jp0532364
   Pancera SM, 2002, LANGMUIR, V18, P3517, DOI 10.1021/la0110693
   PAULA SOD, 2002, T R SOC TROP MED HYG, V96, P266
   Pereira EMA, 2008, COLLOID SURFACE B, V66, P45, DOI 10.1016/j.colsurfb.2008.05.013
   Pereira EMA, 2010, ACS APPL MATER INTER, V2, P2602, DOI 10.1021/am100442f
   Peters T. J., 1996, ALL ALBUMIN
   Serefoglou E, 2007, BIOMACROMOLECULES, V8, P1195, DOI 10.1021/bm061094t
   Sierakowski MR, 2002, CARBOHYD POLYM, V49, P167, DOI 10.1016/S0144-8617(01)00321-6
   Tada D, 2007, MAT SCI ENG C-BIO S, V27, P870, DOI 10.1016/j.msec.2006.10.008
   Taylor ME, 2006, INTRO GLYCOBIOLOGY
   Tlili A, 2005, MAT SCI ENG C-BIO S, V25, P490, DOI 10.1016/j.msec.2005.02.001
   Tretiakov KV, 2009, J PHYS CHEM A, V113, P3799, DOI 10.1021/jp809447m
   VanderVegt W, 1996, COLLOID POLYM SCI, V274, P27, DOI 10.1007/BF00658906
NR 37
TC 13
Z9 13
U1 0
U2 18
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 8
PY 2011
VL 31
IS 3
BP 562
EP 566
DI 10.1016/j.msec.2010.11.020
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 730PE
UT WOS:000288045600009
DA 2020-11-10
ER

PT J
AU Saiki, FA
   Costa, EP
   Fonseca, BA
AF Saiki, Flavia A.
   Costa, Emiliana P.
   Fonseca, Benedito A.
TI VIRAL INTERFERENCE BETWEEN DENGUE-2 AND YELLOW FEVER VIRUSES IN VERO
   CELLS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Saiki, Flavia A.; Costa, Emiliana P.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 518
BP 155
EP 156
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819700519
DA 2020-11-10
ER

PT J
AU Mendonca, PR
   Lobo, RR
   Fonseca, BA
AF Mendonca, Patricia Rolim
   Lobo, Romulo Reboucas
   Fonseca, Benedito A.
TI SEVERE LIVER INFECTION IN AN ADULT PATIENT WITH DENGUE HEMORRHAGIC
   FEVER: EVIDENCE FOR A BETTER USE OF THE NEW WHO DENGUE CASE
   CLASSIFICATION
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Mendonca, Patricia Rolim; Lobo, Romulo Reboucas; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 519
BP 156
EP 156
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819700520
DA 2020-11-10
ER

PT J
AU Suzuki, A
   Rocco, IM
   Ferreira, IB
   Pereira, LE
   Cerroni, MP
   Freitas, PP
   Souza, RP
   Coimbra, TLM
   Petrella, SM
   Fonseca, BA
AF Suzuki, Akemi
   Rocco, Iray M.
   Ferreira, Ivani B.
   Pereira, Luiz E.
   Cerroni, Matheus P.
   Freitas, Patricia P.
   Souza, Renato P.
   Coimbra, Terezinha Lisieux M.
   Petrella, Selma M.
   Fonseca, Benedito A.
TI INVESTIGATION OF ARBOVIRAL INFECTIONS OF BIRDS IN SAO PAULO STATE,
   BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 59th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)
CY NOV 03-07, 2010
CL Atlanta, GA
SP Amer Soc Trop Med & Hyg (ASTMH)
C1 [Suzuki, Akemi; Rocco, Iray M.; Ferreira, Ivani B.; Pereira, Luiz E.; Cerroni, Matheus P.; Souza, Renato P.; Coimbra, Terezinha Lisieux M.; Petrella, Selma M.] Adolfo Lutz Inst, Sao Paulo, Brazil.
   [Freitas, Patricia P.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2010
VL 83
IS 5
SU S
MA 1166
BP 347
EP 347
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 832QF
UT WOS:000295819701533
DA 2020-11-10
ER

PT J
AU Pereira, EMA
   Dario, AF
   Franca, RFO
   Fonseca, BAL
   Petri, DFS
AF Pereira, Edla M. A.
   Dario, Aline F.
   Franca, Rafael F. O.
   Fonseca, Benedito A. L.
   Petri, Denise F. S.
TI Binding of Dengue Virus Partitcles and Dengue Proteins onto Solid
   Surfaces
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE lectin; dengue virus; ellipsometry; AFM; surface energy; polystyrene
ID CONCANAVALIN-A; CONFORMATIONAL-CHANGES; ENVELOPE PROTEIN; FREE-ENERGY;
   JACKFRUIT; PARTICLES; LECTIN; ADSORPTION; CARBOXYMETHYLCELLULOSE;
   IMMOBILIZATION
AB The interaction between dengue virus particles (DENV), sedimentation hemagglutinin particles (SHA), dengue virus envelope protein (Eprot), and solid surfaces was investigated by means of ellipsometry and atomic force microscopy (AFM). The surfaces chosen are bare Si/SiO2 wafers and Si/SiO2 wafers covered with concanavalin A (ConA), jacalin (Jac), polystyrene (PS), or poly(styrene sulfonate) (PSS) films. Adsorption experiments at pH 7.2 and pH 3 onto all surfaces revealed that (i) adsorption of DENV particles took place only onto ConA under pH 7.2, because of specific recognition between glycans on DENV surface and ConA binding site; (ii) DENV particles did not attach to any of the surfaces at pH 3, suggesting the presence of positive charges on DENV surface at this pH, which repel the positively charged lectin surfaces; (iii) SHA particles are positively charged at pH 7.2 and pH 3 because they adhered to negatively charged surfaces at pH 7.2 and repelled positively charged layers at pH 3; and (iv) SHA particles carry polar groups on the surface because they attached to silanol surfaces at pH 3 and avoided hydrophobic PS films at pH 3 and pH 7.2. The adsorption behavior of Eprot at pH 7.2 revealed affinity for ConA > Jac > PSS > PS approximate to bare Si/SiO2 layers. These findings indicate that selectivity of the Eprot adsorption is higher when it is part of virus structure than when it is free in solution. The correlation between surface energy values determined by means of contact angle measurements and DENV, SHA, or Eprot adsorption behavior was used to understand the intermolecular forces at the interfaces. A direct correlation was not found because the contributions from surface energy were probably surpassed by specific contributions.
C1 [Pereira, Edla M. A.; Dario, Aline F.; Petri, Denise F. S.] Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
   [Franca, Rafael F. O.] Univ Sao Paulo, Fac Med Ribeirao Preto, Programa Pos Grad Imunol Basica & Aplicada, Ribeirao Preto, Brazil.
   [Fonseca, Benedito A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, Brazil.
RP Petri, DFS (corresponding author), Univ Sao Paulo, Inst Quim, POB 26077, BR-05513970 Sao Paulo, Brazil.
EM dfsp@iq.usp.br
RI PETRI, DENISE/H-5004-2012; Fonseca, Benedito/F-3252-2012
OI PETRI, DENISE/0000-0003-4814-8357; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007; Fonseca, Benedito/0000-0003-3159-5687
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq/MCT)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
FX The authors acknowledge Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq/MCT) and Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) for financial support.
CR Adamson WA, 1990, PHYS CHEM SURFACES
   AHMED H, 1989, J BIOL CHEM, V264, P9365
   Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Azzam R. M., 1987, ELLIPSOMETRY POLARIZ
   BOCK G, 2006, NOVARTIS FDN S SERIE
   BREWER CF, 1983, BIOCHEMISTRY-US, V22, P3691, DOI 10.1021/bi00284a024
   Briandet R, 2001, COLLOID SURFACE B, V21, P299, DOI 10.1016/S0927-7765(00)00213-7
   BUNNMORENO MM, 1981, J IMMUNOL, V127, P427
   Butti HJ, 1995, LANGMUIR, V11, P4735, DOI 10.1021/la00012a026
   Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363
   Casarano R, 2009, POLYMER, V50, P6218, DOI 10.1016/j.polymer.2009.10.048
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   Castro LBR, 2005, J NANOSCI NANOTECHNO, V5, P2063, DOI 10.1166/jnn.2005.501
   Chaudhury MK, 1996, MAT SCI ENG R, V16, P97, DOI 10.1016/0927-796X(95)00185-9
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223
   Dobrynin AV, 2005, PROG POLYM SCI, V30, P1049, DOI 10.1016/j.progpolymsci.2005.07.006
   Efremova NV, 2000, BIOCHEMISTRY-US, V39, P3441, DOI 10.1021/bi992095r
   Fujimoto J, 2001, LANGMUIR, V17, P56, DOI 10.1021/la000731c
   Harnett EM, 2007, COLLOID SURFACE B, V55, P90, DOI 10.1016/j.colsurfb.2006.11.021
   HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7
   Jacquemart I, 2004, J COLLOID INTERF SCI, V278, P63, DOI 10.1016/j.jcis.2004.05.040
   Jelinek R, 2004, CHEM REV, V104, P5987, DOI 10.1021/cr0300284
   KABIR S, 1995, INT J BIOCHEM CELL B, V27, P147, DOI 10.1016/1357-2725(94)00071-I
   Kosaka PM, 2009, ACS SYM SER, V1019, P223
   Kullolli M, 2008, J SEP SCI, V31, P2733, DOI 10.1002/jssc.200800233
   Marmur A, 2006, SOFT MATTER, V2, P12, DOI 10.1039/b514811c
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Palik E D, 1985, HDB OPTICAL CONSTANT
   Pereira EMA, 2008, COLLOID SURFACE B, V66, P45, DOI 10.1016/j.colsurfb.2008.05.013
   PETRI DFS, 1999, COLLOID POLYM SCI, V277, P673
   REEKE GN, 1975, J BIOL CHEM, V250, P1525
   RUFFET E, 1992, BIOCHEM J, V286, P131, DOI 10.1042/bj2860131
   Smith EA, 2003, J AM CHEM SOC, V125, P6140, DOI 10.1021/ja034165u
   TAYLOR E, 2006, INTRO GLYCOBIOLOGY
   Turkova J, 1999, J CHROMATOGR B, V722, P11, DOI 10.1016/S0378-4347(98)00434-4
   VANDERVALK P, 1983, J BIOMED MATER RES, V17, P807, DOI 10.1002/jbm.820170508
   ZAND R, 1971, P NATL ACAD SCI USA, V68, P2173, DOI 10.1073/pnas.68.9.2173
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 43
TC 9
Z9 9
U1 1
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD SEP
PY 2010
VL 2
IS 9
BP 2602
EP 2610
DI 10.1021/am100442f
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 652OR
UT WOS:000282017700020
PM 20715788
DA 2020-11-10
ER

PT J
AU Castro-Jorge, LA
   Machado, PRL
   Favero, CA
   Borges, MC
   Passos, LMR
   de Oliveira, RM
   Fonseca, BAL
AF Castro-Jorge, Luiza A.
   Machado, Paula R. L.
   Favero, Camila A.
   Borges, Marcos C.
   Passos, Luzia M. R.
   de Oliveira, Rosana Moreira
   Fonseca, Benedito A. L.
TI Clinical Evaluation of the NS1 Antigen-Capture ELISA for Early Diagnosis
   of Dengue Virus Infection in Brazil
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE dengue; NS1; ELISA; IRT-PCR
ID LINKED-IMMUNOSORBENT-ASSAY; NONSTRUCTURAL PROTEIN NS1;
   MONOCLONAL-ANTIBODIES; SENSITIVITY; IMMUNOASSAY; SPECIFICITY; TESTS
AB The fact that the diagnosis of infection with dengue virus is usually made by detecting IgM antibodies during the convalescent phase of the disease interferes with disease management and, consequently, with reducing mortality rates. This study evaluated the sensitivity and specificity of detection of NS1 in samples of patients suspected of acute dengue virus infection in Brazil. The results were used to institute treatment and the sensitivity and specificity of detection of NS1 were compared to the results of detection of IgM, virus isolation, and RT-PCR. Detection of NS1 yielded better results than RTPCR and virus isolation. When considering IgM detection and RT-PCR positive results as "gold standards," the sensitivity and specificity of the NS1 assay were 95.9% and 81.1%, respectively. All patients enrolled in the study were treated promptly and had an uneventful course of the disease. The detection of NS1 provided better results than the diagnostic techniques used currently during the acute phase of disease (RT-PCR and virus isolation). Detection of NS1 is an important tool for the diagnosis of acute dengue infection, particularly in highly endemic areas, allowing for rapid treatment of patients and reduction of disease burden. J. Med. Virol. 82: 1400-1405, 2010. (C) 2010 Wiley-Liss, Inc.
C1 [Castro-Jorge, Luiza A.; Machado, Paula R. L.; Favero, Camila A.; Borges, Marcos C.; Passos, Luzia M. R.; de Oliveira, Rosana Moreira; Fonseca, Benedito A. L.] Univ Sao Paulo, Sch Med Ribeirao Preto, BR-14049900 Sao Paulo, Brazil.
RP Fonseca, BAL (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Ave Bandeirantes 3900, BR-14049900 Sao Paulo, Brazil.
EM baldfons@fmrp.usp.br
RI de Castro Jorge, Luiza Antunes/D-3773-2009; Borges, Marcos
   Carvalho/A-3585-2014; Fonseca, Benedito/F-3252-2012
OI Borges, Marcos Carvalho/0000-0001-6280-0714; Machado,
   Paula/0000-0002-3085-9778; Fonseca, Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Sao
   Paulo, BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [06-587926, 07/04326-7]
FX Grant sponsor: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP), Sao Paulo, Brazil; Grant numbers: 06-587926; 07/04326-7.
CR Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Ayres M., 2005, BIOESTAT APLICACOES
   Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Chuansumrit A, 2008, PEDIATR INFECT DIS J, V27, P43, DOI 10.1097/INF.0b013e318150666d
   De Paula Sérgio Oliveira, 2004, Braz J Infect Dis, V8, P390, DOI 10.1590/S1413-86702004000600002
   *DENG DIAGN, 2005, DENGUE B, V29, P220
   Deubel Vincent, 1997, P335
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gomes-Ruiz AC, 2006, J MED VIROL, V78, P760, DOI 10.1002/jmv.20620
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   HENCHAL EA, 1983, AM J TROP MED HYG, V32, P164, DOI 10.4269/ajtmh.1983.32.164
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003
   Kumarasamy V, 2007, SMJ Singapore Medical Journal, V48, P669
   Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   *WHO, 2005, WHOFCHCAH0513
   World Health Organization, 1997, DENG HEM FEV DIAGN T
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 29
TC 22
Z9 22
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD AUG
PY 2010
VL 82
IS 8
BP 1400
EP 1405
DI 10.1002/jmv.21814
PG 6
WC Virology
SC Virology
GA 617IH
UT WOS:000279273700016
PM 20578057
DA 2020-11-10
ER

PT J
AU Barreira, AA
   Lopes, LC
   Santos, AC
   Ramos, JO
   Bastos, PG
   Marques, VD
   Castro-Jorge, LA
   Fonseca, BA
   Marques, W
AF Barreira, A. A.
   Lopes, L. C.
   Santos, A. C.
   Ramos, J. O.
   Bastos, P. G.
   Marques, V. D.
   Castro-Jorge, L. A.
   Fonseca, B. A.
   Marques, W., Jr.
TI Atypical Guillain-Barre syndrome associated to dengue fever
SO JOURNAL OF NEUROLOGY
LA English
DT Meeting Abstract
CT 20th Meeting of the European-Neurological-Society
CY JUN 19-23, 2010
CL Berlin, GERMANY
SP European Neurol Soc
C1 [Barreira, A. A.; Lopes, L. C.; Santos, A. C.; Ramos, J. O.; Bastos, P. G.; Marques, V. D.; Castro-Jorge, L. A.; Fonseca, B. A.; Marques, W., Jr.] Med Sch Ribeirao Preto, Ribeirao Preto, Brazil.
RI Lopes, Luciane/H-3159-2019; Barreira, Amilton/A-1159-2008; de Castro
   Jorge, Luiza Antunes/D-3773-2009; Lopes, Luis Felipe Dias/I-5809-2012
OI Lopes, Luciane/0000-0002-3684-3275; Lopes, Luis Felipe
   Dias/0000-0002-2438-0226
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
J9 J NEUROL
JI J. Neurol.
PD JUN
PY 2010
VL 257
SU 1
MA P332
BP S106
EP S106
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 600AH
UT WOS:000277955200309
DA 2020-11-10
ER

PT J
AU Cavicchioli, M
   Massabni, AC
   Heinrich, TA
   Costa-Neto, CM
   Abrao, EP
   Fonseca, BAL
   Castellano, EE
   Corbi, PP
   Lustri, WR
   Leite, CQF
AF Cavicchioli, Mauricio
   Massabni, Antonio C.
   Heinrich, Tassiele A.
   Costa-Neto, Claudio M.
   Abrao, Emiliana P.
   Fonseca, Benedito A. L.
   Castellano, Eduardo E.
   Corbi, Pedro P.
   Lustri, Wilton R.
   Leite, Clarice Q. F.
TI Pt(II) and Ag(I) complexes with acesulfame: Crystal structure and a
   study of their antitumoral, antimicrobial and antiviral activities
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE Antitumor agents; Antibiotic; Acesulfame-K; Platinum; Silver
ID GROUP DOMAIN PROTEINS; SILVER NANOPARTICLES; TRIPHENYLPHOSPHINE LIGANDS;
   MYCOBACTERIUM-TUBERCULOSIS; NUCLEOTIDE EXCISION; CROSS-LINKS; DNA;
   BURNS; NITRATE; IDENTIFICATION
AB Two new complexes of platinum(II) and silver(I) with acesulfame were synthesized. Acesulfame is in the anionic form acesulfamate (ace). The structures of both complexes were determined by X-ray crystallography. For K-2[PtCl2(ace)(2)] the platinum atom is coordinated to two Cl- and two N-acesulfamate atoms forming a trans-square planar geometry. Each K+ ion interacts with two oxygen atoms of the S(=O)(2) group of each acesulfamate. For the polymeric complex [Ag(ace)](n) the water molecule bridges between two crystallographic equivalent Agl atoms which are related each other by a twofold symmetry axis. Two Agl atoms, related to each other by a symmetry centre, make bond contact with two equivalent oxygen atoms. These bonds give rise to infinite chains along the unit cell diagonal in the ac plane. The in vitro cytotoxic analyses for the platinum complex using HeLa (human cervix cancer) cells show its low activity when compared to the vehicle-treated cells. The Ag(I) complex submitted to in vitro antimycobacterial tests, using the Microplate Alamar Blue (MABA) method, showed a good activity against Mycobacterium tuberculosis, responsible for tuberculosis, with a minimal inhibitory concentration (MIC) value of 11.6 mu M. The Ag(I) complex also presented a promising activity against Gram negative (Escherichia colt and Pseudomonas aeruginosa) and Gram positive (Enterococcus faecalis) microorganisms. The complex K-2[PtCl2(ace)(2)] was also evaluated for antiviral properties against dengue virus type 2 (New Guinea C strain) in Vero cells and showed a good inhibition of dengue virus type 2 (New Guinea G strain) replication at 200 mu M, when compared to vehicle-treated cells. (C) 2010 Elsevier Inc. All rights reserved.
C1 [Cavicchioli, Mauricio; Massabni, Antonio C.] Univ Estadual Paulista Julio Mesquita Filho UNESP, Inst Quim, Rua Prof Francisco Degni S-N, BR-14801970 Araraquara, SP, Brazil.
   [Heinrich, Tassiele A.; Costa-Neto, Claudio M.; Abrao, Emiliana P.; Fonseca, Benedito A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Castellano, Eduardo E.] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
   [Corbi, Pedro P.] Univ Estadual Campinas, UNICAMP, Inst Quim, Lab Quim Bioinorgan & Med, BR-13083970 Campinas, SP, Brazil.
   [Lustri, Wilton R.] Ctr Univ Araraquara UNIARA, Dept Ciencias Biol & Saude, Assoc Sao Bento de Ensino, BR-14801320 Araraquara, SP, Brazil.
   [Leite, Clarice Q. F.] Univ Estadual Paulista, UNESP, Fac Ciencias Farmaceut, BR-14801902 Araraquara, SP, Brazil.
RP Cavicchioli, M (corresponding author), Univ Estadual Paulista Julio Mesquita Filho UNESP, Inst Quim, Rua Prof Francisco Degni S-N, BR-14801970 Araraquara, SP, Brazil.
EM mauriciocavicchioli@gmail.com
RI Leite, Clarice/D-9492-2012; Lustri, Wilton Rogerio/AAG-3992-2020;
   Massabni, Antonio/D-2321-2014; Corbi, Pedro P/B-7639-2012; Costa-Neto,
   Claudio M/K-7291-2015; Castellano, Eduardo Ernesto/AAR-5487-2020;
   castellano, eduardo ernesto/K-7925-2018; Cavicchioli,
   Mauricio/A-3073-2008; Massabni, Antonio Carlos/AAI-2151-2019; Fonseca,
   Benedito/F-3252-2012
OI Corbi, Pedro P/0000-0002-7478-0877; Costa-Neto, Claudio
   M/0000-0002-7256-6412; Castellano, Eduardo Ernesto/0000-0003-0499-8907;
   castellano, eduardo ernesto/0000-0003-0499-8907; Cavicchioli,
   Mauricio/0000-0002-6557-7391; Massabni, Antonio
   Carlos/0000-0002-4190-1505; Lustri, Wilton Rogerio/0000-0001-6627-4758;
   Fonseca, Benedito/0000-0003-3159-5687
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/00174-2]
FX The authors are grateful to the Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo - FAPESP (Proc. 2005/00174-2) for financial support.
CR BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   BELLINGER CG, 1970, PLAST RECONSTR SURG, V45, P582, DOI 10.1097/00006534-197006000-00009
   BERNERSPRICE SJ, 1988, J INORG BIOCHEM, V33, P285, DOI 10.1016/0162-0134(88)80007-2
   Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Cavicchioli M, 2007, ARCH PHARM, V340, P538, DOI 10.1002/ardp.200700040
   Cavicchioli M, 2007, INORG CHIM ACTA, V360, P3055, DOI 10.1016/j.ica.2007.02.040
   Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004
   COPPENS P, 1965, ACTA CRYSTALLOGR, V18, P1035, DOI 10.1107/S0365110X65002487
   de Gracia CG, 2001, BURNS, V27, P67, DOI 10.1016/S0305-4179(00)00061-9
   Dye C, 2002, J INFECT DIS, V185, P1197, DOI 10.1086/339818
   EASTMAN A, 1986, BIOCHEMISTRY-US, V25, P3912, DOI 10.1021/bi00361a026
   *ENR NON, 1997, COLLECT
   Farrugia L. J., 1997, J APPL CRYSTALLOGR, V30, P565, DOI DOI 10.1107/S0021889897003117
   FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Houng HSH, 2001, J VIROL METHODS, V95, P19, DOI 10.1016/S0166-0934(01)00280-4
   *INT CTR DIFFR DAT, 1999, 040802 INT CTR DIFFR
   *INT CTR DIFFR DAT, 1999, 441414 INT CTR DIFFR
   *INT CTR DIFFR DAT, 1999, 040783 INT CTR DIFFR
   Kasparkova J, 2002, J BIOL CHEM, V277, P48076, DOI 10.1074/jbc.M208016200
   Kent P. T., 1985, GUIDE LEVEL 3 LAB
   Klasen HJ, 2000, BURNS, V26, P131, DOI 10.1016/S0305-4179(99)00116-3
   Klasen HJ, 2000, BURNS, V26, P117, DOI 10.1016/S0305-4179(99)00108-4
   Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MOYER CA, 1965, ARCH SURG-CHICAGO, V90, P812
   NAKAMOTO, 1997, INFRARED RAMAN SPECT, P387
   *NAT COMM CLIN LAB, 1993, APPR STAND NCCLS PUB
   Nomiya K, 2000, INORG CHIM ACTA, V298, P24, DOI 10.1016/S0020-1693(99)00401-6
   Nomiya K, 2000, B CHEM SOC JPN, V73, P1143, DOI 10.1246/bcsj.73.1143
   NOMIYA K, 1995, J INORG BIOCHEM, V58, P255, DOI 10.1016/0162-0134(94)00059-J
   Nomiya K, 2002, J CHEM SOC DALTON, P2483, DOI 10.1039/b200684g
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002
   REED E, 1987, P NATL ACAD SCI USA, V84, P5024, DOI 10.1073/pnas.84.14.5024
   ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0
   Sheldrick G.M., 1997, SHELXS 97 PROGRAM CR
   Sheldrick G.M., 1997, SHELXL 97 PROGRAM CR
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   THURMAN RB, 1988, CRIT REV ENV CONTR, V18, P295
   Vaerewijck MJM, 2005, FEMS MICROBIOL REV, V29, P911, DOI 10.1016/j.femsre.2005.02.001
   WHO, 2007, WHOHTMTB2007376
   Zehnulova J, 2001, J BIOL CHEM, V276, P22191, DOI 10.1074/jbc.M103118200
   Zhang C, 2003, CURR OPIN CHEM BIOL, V7, P28, DOI 10.1016/S1367-5931(02)00015-7
NR 46
TC 52
Z9 54
U1 2
U2 53
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
EI 1873-3344
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD MAY
PY 2010
VL 104
IS 5
BP 533
EP 540
DI 10.1016/j.jinorgbio.2010.01.004
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 578DW
UT WOS:000276274700006
PM 20149461
DA 2020-11-10
ER

PT J
AU Farias, KJ
   Machado, PR
   Fonseca, BA
AF Farias, Kleber Juvenal
   Machado, Paula Renata
   Fonseca, Benedito Antonio
TI STUDY OF THE REPLICATION OF DENGUE-2 VIRUS IN U937 CELLS UNDER THE
   ACTION OF CHLOROQUINE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Farias, Kleber Juvenal; Machado, Paula Renata; Fonseca, Benedito Antonio] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
RI FARIAS, KLEBER/AAC-9815-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 93
BP 26
EP 27
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956700094
DA 2020-11-10
ER

PT J
AU Machado, PR
   Farias, K
   Fonseca, B
AF Machado, Paula Renata
   Farias, Kleber
   Fonseca, Benedito
TI DETECTION AND QUANTIFICATION OF HUMAN HERPESVIRUS 8 IN SAMPLES OF
   PATIENTS WITH AIDS-ASSOCIATED KAPOSI'S SARCOMA BY REAL TIME PCR
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Machado, Paula Renata; Farias, Kleber; Fonseca, Benedito] Univ Sao Paulo, BR-14049 Ribeirao Preto, Brazil.
RI FARIAS, KLEBER/AAC-9815-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 291
BP 82
EP 82
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956700291
DA 2020-11-10
ER

PT J
AU Castro-Jorge, LA
   Jorge, DM
   Fonseca, BA
AF Castro-Jorge, Luiza A.
   Jorge, Daniel M.
   Fonseca, Benedito A.
TI DENV-3 GENOTYPE III IS CIRCULATING IN SAO PAULO STATE, BRAZIL, DURING
   THE LAST FIVE YEARS, AND IT HAS NOT BEEN ASSOCIATED WITH THE SEVERE
   PRESENTATIONS OF THE DISEASE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Castro-Jorge, Luiza A.; Jorge, Daniel M.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Jorge, Daniel M/B-4533-2010; de Castro Jorge, Luiza Antunes/D-3773-2009
OI Jorge, Daniel M/0000-0002-8387-3215; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 434
BP 124
EP 124
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956700434
DA 2020-11-10
ER

PT J
AU Sobral, MC
   Castro-Jorge, LA
   Passos, LM
   Oliveira, RM
   Fonseca, BA
AF Sobral, Mariana C.
   Castro-Jorge, Luiza A.
   Passos, Luzia M.
   Oliveira, Rosana Moreira
   Fonseca, Benedito A.
TI DETECTION OF ASYMPTOMATIC INFECTION AMONG RELATIVES OF DENGUE PATIENTS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 18-22, 2009
CL Washington, DC
SP Amer Soc Trop Med & Hyg
C1 [Sobral, Mariana C.; Castro-Jorge, Luiza A.; Passos, Luzia M.; Oliveira, Rosana Moreira; Fonseca, Benedito A.] Sch Med, Ribeirao Preto, SP, Brazil.
RI de Castro Jorge, Luiza Antunes/D-3773-2009
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2009
VL 81
IS 5
SU S
MA 781
BP 226
EP 226
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 521WK
UT WOS:000271956701197
DA 2020-11-10
ER

PT J
AU Borges, MC
   Colares, JKB
   Lima, DM
   Fonseca, BAL
AF Borges, Marcos Carvalho
   Baima Colares, Jeova Keny
   Lima, Danielle Malta
   Lopes Fonseca, Benedito Antonio
TI Advantages and Pitfalls of the Polymerase Chain Reaction in the
   Diagnosis of Esophageal Ulcers in AIDS Patients
SO DIGESTIVE DISEASES AND SCIENCES
LA English
DT Article
DE Microbiology; Sexually transmitted diseases; Diagnosis; DNA bacterial;
   Esophageal disease
ID HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTION; URINE SAMPLES;
   CYTOMEGALOVIRUS; DISEASE; BIOPSY; DIFFERENTIATION; IDENTIFICATION;
   AMPLIFICATION; HYBRIDIZATION
AB HIV-1-infected patients frequently have opportunistic esophageal infections which, when associated with severe immunodeficiency, can be attributed to unusual pathogens. The clinical presentation of several esophageal diseases is similar and the best method for a specific diagnosis of these patients has not been well defined. To evaluate the role of the polymerase chain reaction (PCR) in the etiologic definition of esophageal ulcers in HIV-1-infected patients, 96 esophageal biopsies from 79 HIV-1-infected patients were processed by PCR using specific primers for cytomegalovirus (CMV), herpes virus (HSV), human papilloma virus (HPV), HIV-1, Mycobacterium tuberculosis, Mycobacterium avium, Mycobacterium intracellulare, Treponema pallidum, and Haemophilus ducreyi. The PCR results were compared to the histopathologic results. Seventy-nine patients were studied (mean age: 34 years; 62% men; median CD4 + T cell = 103.59 cells/mu l (range 1-795.2 cells/mu l). The most common endoscopic findings were as follows: esophageal candidiasis (37.1%), esophageal ulcers (24.7%), esophagitis (11.2%), and lugol-negative areas (10.1%). The histopathologic findings in the esophageal ulcers (22 biopsies) were non-specific inflammation (31.8%), HSV (36.4%), Candida (13.6%), CMV (13.6%), or HPV disease (4.5%). In the esophageal ulcer biopsies, the PCR results were negative in 27.6% of cases, and positive for HIV (65.5%), CMV (31%), HPV (20.7%), HSV (10.3%), and H. ducreyi (6.9%). The histopathologic examination did not identify a pathogen or identified only Candida in 15 biopsies of esophageal ulcers. PCR was positive in ten (66.7%) and negative in five (33.3%) of these biopsies (idiopathic ulcers). PCR detected: HIV (53.3%), CMV (20%), HPV (13.3%), and H. ducreyi (6,7%). PCR detected more etiologic agents in esophageal ulcers than histopathology and was able to detect unusual pathogens. On the other hand, sometimes more than one pathogen was detected in the esophageal ulcers, making it difficult to reach an accurate diagnosis. This finding indicates the need for more studies to evaluate the benefit of this method in the routine evaluation of esophageal ulcer biopsies in HIV-1-infected patients.
C1 [Borges, Marcos Carvalho; Baima Colares, Jeova Keny; Lima, Danielle Malta; Lopes Fonseca, Benedito Antonio] Univ Sao Paulo, Dept Internal Med, Mol Virol Lab, Sch Med, BR-14048900 Ribeirao Preto, SP, Brazil.
   [Borges, Marcos Carvalho] Univ Fed Sao Carlos, Dept Med, BR-13560 Sao Carlos, SP, Brazil.
RP Fonseca, BAL (corresponding author), Univ Sao Paulo, Dept Internal Med, Mol Virol Lab, Sch Med, BR-14048900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Borges, Marcos Carvalho/A-3585-2014; Lima, Danielle/A-6108-2013;
   Colares, Jeova Keny Baima/C-5257-2014; Fonseca, Benedito/F-3252-2012
OI Borges, Marcos Carvalho/0000-0001-6280-0714; Lima,
   Danielle/0000-0003-2734-6768; Colares, Jeova Keny
   Baima/0000-0003-1367-6272; Fonseca, Benedito/0000-0003-3159-5687
CR Ahmed HJ, 2003, SEX TRANSM DIS, V30, P114, DOI 10.1097/00007435-200302000-00004
   Baron JM, 1996, J MED VIROL, V49, P279, DOI 10.1002/(SICI)1096-9071(199608)49:4&lt;279::AID-JMV4&gt;3.0.CO;2-0
   BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472
   BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567
   BORGES MC, 2008, INT J STD A IN PRESS
   Borum ML, 1999, J CLIN GASTROENTEROL, V28, P260, DOI 10.1097/00004836-199904000-00018
   BURSTAIN JM, 1991, J CLIN MICROBIOL, V29, P62, DOI 10.1128/JCM.29.1.62-69.1991
   Centurioni MG, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-77
   CHAWLA SK, 1994, AM J GASTROENTEROL, V89, P411
   Chen ZH, 1996, J CLIN MICROBIOL, V34, P1267, DOI 10.1128/JCM.34.5.1267-1269.1996
   Chong VH, 2005, J GASTROEN HEPATOL, V20, P722, DOI 10.1111/j.1440-1746.2005.03793.x
   CHUI L, 1993, J CLIN MICROBIOL, V31, P659, DOI 10.1128/JCM.31.3.659-664.1993
   CONNOLLY GM, 1989, GUT, V30, P1033, DOI 10.1136/gut.30.8.1033
   Covas DT, 1998, J ACQ IMMUN DEF SYND, V19, P74, DOI 10.1097/00042560-199809010-00012
   DEMMLER GJ, 1988, J INFECT DIS, V158, P1177, DOI 10.1093/infdis/158.6.1177
   EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977
   GILL MJ, 1992, AIDS, V6, P553, DOI 10.1097/00002030-199206000-00005
   GOODGAME RW, 1993, AM J GASTROENTEROL, V88, P338
   GRADON JD, 1992, CLIN INFECT DIS, V15, P134, DOI 10.1093/clinids/15.1.134
   Houghton J, 1997, J INFECT DIS, V175, P1216, DOI 10.1086/593671
   Knox TA, 2000, AM J GASTROENTEROL, V95, P3482, DOI 10.1111/j.1572-0241.2000.03365.x
   KOTLER DP, 1989, AM J GASTROENTEROL, V84, P313
   Lewis DA, 2000, SEX TRANSM INFECT, V76, P137, DOI 10.1136/sti.76.2.137
   Lima DM, 2005, CHEST, V127, P1283, DOI 10.1378/chest.127.4.1283
   Monkemuller Klaus E., 2000, Comprehensive Therapy, V26, P163, DOI 10.1007/s12019-000-0004-y
   Mussi-Pinhata M M, 1994, J Pediatr (Rio J), V70, P338
   Peter A, 2004, CLIN TRANSPLANT, V18, P580, DOI 10.1111/j.1399-0012.2004.00230.x
   Quarto G, 2008, Minerva Gastroenterol Dietol, V54, P317
   Rebollo MJ, 2006, DIAGN MICR INFEC DIS, V56, P141, DOI 10.1016/j.diagmicrobio.2006.03.018
   SCHWARTZ DA, 1992, HUM PATHOL, V23, P1019, DOI 10.1016/0046-8177(92)90263-3
   SMITH PD, 1993, J INFECT DIS, V167, P547, DOI 10.1093/infdis/167.3.547
   THEISE ND, 1991, AM J GASTROENTEROL, V86, P1123
   Wilcox CM, 2004, CLIN GASTROENTEROL H, V2, P564, DOI 10.1016/S1542-3565(04)00239-3
   WILCOX CM, 1992, AM J MED, V92, P412, DOI 10.1016/0002-9343(92)90272-D
   WILCOX CM, 1994, AM J GASTROENTEROL, V89, P2163
   WILCOX CM, 1995, ANN INTERN MED, V123, P143, DOI 10.7326/0003-4819-123-2-199507150-00010
   Wilcox CM, 1996, GASTROINTEST ENDOSC, V44, P587, DOI 10.1016/S0016-5107(96)70014-7
   Yamamoto AY, 2001, J VIROL METHODS, V97, P159, DOI 10.1016/S0166-0934(01)00347-0
NR 38
TC 4
Z9 5
U1 0
U2 7
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0163-2116
EI 1573-2568
J9 DIGEST DIS SCI
JI Dig. Dis. Sci.
PD SEP
PY 2009
VL 54
IS 9
BP 1933
EP 1939
DI 10.1007/s10620-008-0584-4
PG 7
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 474ZP
UT WOS:000268324000017
PM 19051024
DA 2020-11-10
ER

PT J
AU Borges, MC
   Colares, JKB
   Lima, DM
   Fonseca, BAL
AF Borges, M. C.
   Colares, J. K. B.
   Lima, D. M.
   Fonseca, B. A. L.
TI Haemophilus ducreyi detection by polymerase chain reaction in
   oesophageal lesions of HIV patients
SO INTERNATIONAL JOURNAL OF STD & AIDS
LA English
DT Article
DE chancroid; microbiology; sexually transmitted diseases; diagnosis; DNA
   bacterial
ID ACQUIRED-IMMUNODEFICIENCY-SYNDROME; VIRUS INFECTION; DIAGNOSIS;
   ULCERATION; MANAGEMENT; SYMPTOMS; DISEASE; ULCERS
AB HIV patients frequently have opportunistic oesophageal infections. We report Haemophilus ducreyi genetic material detected by polymerase chain reaction in biopsies of oesophageal lesions in three HIV-1-infected patients. This finding may be an indication of its aetiopathological role in oesophageal lesions of HIV patients.
C1 [Fonseca, B. A. L.] Univ Sao Paulo, Med Sch Ribeirao Preto, Mol Virol Lab, Dept Internal Med, BR-14048900 Ribeirao Preto, SP, Brazil.
   [Borges, M. C.] Univ Sao Carlos, Dept Med, Sao Carlos, SP, Brazil.
RP Fonseca, BAL (corresponding author), Univ Sao Paulo, Med Sch Ribeirao Preto, Mol Virol Lab, Dept Internal Med, Av Bandeirantes 3900, BR-14048900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Borges, Marcos Carvalho/A-3585-2014; Lima, Danielle/A-6108-2013;
   Colares, Jeova Keny Baima/C-5257-2014; Fonseca, Benedito/F-3252-2012
OI Borges, Marcos Carvalho/0000-0001-6280-0714; Lima,
   Danielle/0000-0003-2734-6768; Colares, Jeova Keny
   Baima/0000-0003-1367-6272; Fonseca, Benedito/0000-0003-3159-5687
CR BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567
   Bong CTH, 2002, MICROBES INFECT, V4, P1141, DOI 10.1016/S1286-4579(02)01639-8
   CHAPEL TA, 1977, SEX TRANSM DIS, V4, P150, DOI 10.1097/00007435-197710000-00008
   CHUI L, 1993, J CLIN MICROBIOL, V31, P659, DOI 10.1128/JCM.31.3.659-664.1993
   CONNOLLY GM, 1989, GUT, V30, P1033, DOI 10.1136/gut.30.8.1033
   DANGOR Y, 1993, SEX TRANSM DIS, V20, P5, DOI 10.1097/00007435-199301000-00002
   Houghton J, 1997, J INFECT DIS, V175, P1216, DOI 10.1086/593671
   JONASSON JA, 1993, INT J STD AIDS, V4, P317, DOI 10.1177/095646249300400602
   JOSEPH AK, 1994, DERMATOL CLIN, V12, P1
   KOTLER DP, 1989, AM J GASTROENTEROL, V84, P313
   Lewis DA, 2006, SEX TRANSM INFECT, V82, P19, DOI 10.1136/sti.2006.023127
   Lewis DA, 2003, SEX TRANSM INFECT, V79, P68, DOI 10.1136/sti.79.1.68
   SCHMID GP, 1995, J CLIN MICROBIOL, V33, P3257, DOI 10.1128/JCM.33.12.3257-3259.1995
   STURM AW, 1987, GENITOURIN MED, V63, P98
   Ussher JE, 2007, CLIN INFECT DIS, V44, pE85, DOI 10.1086/515404
   WILCOX CM, 1992, AM J MED, V92, P412, DOI 10.1016/0002-9343(92)90272-D
   WILCOX CM, 1995, ANN INTERN MED, V123, P143, DOI 10.7326/0003-4819-123-2-199507150-00010
   Wu JJ, 2004, CLIN DERMATOL, V22, P499, DOI 10.1016/j.clindermatol.2004.07.008
NR 18
TC 2
Z9 2
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0956-4624
EI 1758-1052
J9 INT J STD AIDS
JI Int. J. STD AIDS
PD APR
PY 2009
VL 20
IS 4
BP 238
EP 240
DI 10.1258/ijsa.2008.008317
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 434UP
UT WOS:000265299900006
PM 19304967
DA 2020-11-10
ER

PT J
AU Castro, LA
   Favero, CA
   Machado, PR
   Borges, MC
   Fonseca, BA
AF Castro, Luiza A.
   Favero, Camila A.
   Machado, Paula R.
   Borges, Marcos C.
   Fonseca, Benedito A.
TI EVALUATION OF NS1 PROTEIN DETECTION AS A DIAGNOSTIC METHOD FOR DENGUE-3
   INFECTION IN BRAZIL
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Castro, Luiza A.; Favero, Camila A.; Machado, Paula R.; Borges, Marcos C.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Borges, Marcos Carvalho/A-3585-2014
OI Borges, Marcos Carvalho/0000-0001-6280-0714
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 116
BP 34
EP 35
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644600117
DA 2020-11-10
ER

PT J
AU Gomes-Ruiz, AC
   Silva, BM
   Bonjardim, CA
   Fonseca, BA
AF Gomes-Ruiz, Alessandra C.
   Silva, Breno M.
   Bonjardim, Claudio A.
   Fonseca, Benedito A.
TI VIRUS REPLICATION IS INHIBITED BY RNA INTERFERENCE (RNAI) DIRECTED TO
   DIFFERENT DENGUE GENOMIC REGIONS
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Gomes-Ruiz, Alessandra C.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [Bonjardim, Claudio A.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RI Bonjardim, Claudio A/J-2601-2014; silva, breno/W-5122-2018
OI silva, breno/0000-0003-2472-8111
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 117
BP 35
EP 35
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644600118
DA 2020-11-10
ER

PT J
AU Fonseca, BA
   Favero, CA
   Castro, LA
   Borges, MC
AF Fonseca, Benedito A.
   Favero, Camila A.
   Castro, Luiza A.
   Borges, Marcos C.
TI CHLOROQUINE IMPROVES PAIN AND WELL-BEING OF DENGUE PATIENTS BUT DOES NOT
   INFLUENCE THE PRESENCE OF FEVER AND DURATION OF THE DISEASE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 57th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY DEC 07-11, 2008
CL New Orleans, LA
SP Amer Soc Trop Med & Hyg
C1 [Fonseca, Benedito A.; Favero, Camila A.; Castro, Luiza A.; Borges, Marcos C.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI Borges, Marcos Carvalho/A-3585-2014
OI Borges, Marcos Carvalho/0000-0001-6280-0714
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD DEC
PY 2008
VL 79
IS 6
MA 124
BP 37
EP 37
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 382ZT
UT WOS:000261644600125
DA 2020-11-10
ER

PT J
AU Pereira, EMA
   Sierakowski, MR
   Jo, TA
   Moreira, RA
   Monteiro-Moreira, ACO
   Franca, RFO
   Fonseca, BAL
   Petri, DFS
AF Pereira, Edla M. A.
   Sierakowski, Maria Rita
   Jo, Tatiane A.
   Moreira, Renato A.
   Monteiro-Moreira, Ana Cristina O.
   Franca, Rafael F. O.
   Fonseca, Benedito A. L.
   Petri, Denise F. S.
TI Lectins and/or xyloglucans/alginate layers as supports for
   immobilization of dengue virus particles
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE xyloglucan; lectin; dengue virus; ellipsometry; AFM
ID AMINO-TERMINATED SURFACES; BOVINE SERUM-ALBUMIN; X-RAY-SCATTERING;
   CONCANAVALIN-A; CONFORMATIONAL-CHANGES; ADSORPTION BEHAVIOR; DECORATED
   PARTICLES; ENVELOPE PROTEIN; HEPARAN-SULFATE; ALGINIC ACID
AB Formation of stable thin films of mixed xyloglucan (XG) and alginate (ALG) onto Si/SiO2 wafers was achieved under pH 11.6, 50 mM CaCl2, and at 70 degrees C. XG-ALG films presented mean thickness of (16 +/- 2) nun and globules rich surface, as evidenced by means of ellipsometry and atomic force microscopy (AFM), respectively. The adsorption of two glucose/mannose-binding seed (Canavalia ensiformis and Dioclea altissima) lectins, coded here as ConA and DAlt, onto XG-ALG surfaces took place under pH 5. Under this condition both lectins present positive net charge. ConA and DAIt adsorbed irreversibly onto XG-ALG forming homogenous monolayers similar to(4 +/- 1)nm thick. Lectins adsorption was mainly driven by electrostatic interaction between lectins positively charged residues and carboxylated (negatively charged) ALG groups. Adhesion of four serotypes of dengue virus, DENV (1-4), particles to XG-ALG surfaces were observed by ellipsometry and AFM. The attachment of dengue particles onto XG-ALG films might be mediated by (i) H bonding between E protein (located at virus particle surface) polar residues and hydroxyl groups present on XG-ALG surfaces and (ii) electrostatic interaction between E protein positively charged residues and ALG carboxylic groups. DENV-4 serotype presented the weakest adsorption onto XG-ALG surfaces, indicating that E protein on DENV-4 surface presents net charge (amino acid sequence) different from E proteins of other serotypes. All four DENV particles serotypes adsorbed similarly onto lectin films adsorbed. Nevertheless, the addition of 0.005 mol/L of mannose prevented dengue particles from adsorbing onto lectin films. XG-ALG and lectin layers serve as potential materials for the development of diagnostic methods for dengue. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Pereira, Edla M. A.; Petri, Denise F. S.] Univ Sao Paulo, Inst Quim, BR-05513970 Sao Paulo, Brazil.
   [Sierakowski, Maria Rita; Jo, Tatiane A.] Univ Fed Parana, Dept Quim, BIOPOL, BR-80060000 Curitiba, Parana, Brazil.
   [Moreira, Renato A.; Monteiro-Moreira, Ana Cristina O.] Univ Fortaleza, Ctr Ciencias Saude, Fortaleza, Ceara, Brazil.
   [Franca, Rafael F. O.; Fonseca, Benedito A. L.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049 Ribeirao Preto, Brazil.
RP Petri, DFS (corresponding author), Univ Sao Paulo, Inst Quim, POB 26077, BR-05513970 Sao Paulo, Brazil.
EM dfsp@iq.usp.br
RI Sierakowski, Maria R/H-9213-2013; Monteiro-Moreira, Ana Cristina
   O/F-3685-2014; PETRI, DENISE/H-5004-2012; Petri, Denise/L-5084-2019;
   Fonseca, Benedito/F-3252-2012
OI Sierakowski, Maria R/0000-0002-8061-1199; Monteiro-Moreira, Ana Cristina
   O/0000-0002-3606-6808; PETRI, DENISE/0000-0003-4814-8357; Moreira,
   Renato de Azevedo/0000-0002-9626-6086; Fonseca,
   Benedito/0000-0003-3159-5687; Freitas de Oliveira Franca,
   Rafael/0000-0002-1846-6007
FU Conselho Nacional de Desenvolvimento Cientifico a Tecnologico
   (CNPq/MCT)National Council for Scientific and Technological Development
   (CNPq); Fundacao Araucaria and Funda ao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP)
FX The authors acknowledge Conselho Nacional de Desenvolvimento Cientifico
   a Tecnologico (CNPq/MCT), Fundacao Araucaria and Funda ao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) for financial support.
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Alper J, 2001, SCIENCE, V291, P2339, DOI 10.1126/science.291.5512.2339
   Avaltroni F, 2007, BIOMACROMOLECULES, V8, P106, DOI 10.1021/bm060655d
   Azzam R. M. A., 1978, ELLIPSOMETRY POLARIZ
   Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729
   BHUSHAN B, 2004, APPL SCANNING PROBE
   Bock G., 2006, NEW TREATMENT STRATE
   Box GEP, 1978, STAT EXPT INTRO DESI
   Brandrup J., 1966, POLYM HDB
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   Castro LBR, 2005, J NANOSCI NANOTECHNO, V5, P2063, DOI 10.1166/jnn.2005.501
   Castro LBR, 2007, J PHYS CHEM B, V111, P8520, DOI 10.1021/jp0686543
   De Paula SO, 2002, T ROY SOC TROP MED H, V96, P266, DOI 10.1016/S0035-9203(02)90094-5
   DRAGET KI, 1994, CARBOHYD POLYM, V25, P31, DOI 10.1016/0144-8617(94)90159-7
   GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7
   HEINZE T, 2005, ADV POLYM SCI POLYSA, V1
   Jelinek R, 2004, CHEM REV, V104, P5987, DOI 10.1021/cr0300284
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g
   Maciel JD, 2007, CARBOHYD POLYM, V69, P522, DOI 10.1016/j.carbpol.2007.01.013
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moreira RA, 1997, PHYTOCHEMISTRY, V46, P139, DOI 10.1016/S0031-9422(97)00262-8
   MORRIS ER, 1978, CARBOHYD RES, V66, P145, DOI 10.1016/S0008-6215(00)83247-4
   Palik E D, 1985, HDB OPTICAL CONSTANT
   Pancera SM, 2005, MACROMOL BIOSCI, V5, P331, DOI 10.1002/mabi.200400206
   QUEIROZ JC, 2007, NOVA, V30, P909
   REEKE GN, 1975, CONCANAVALIN
   Rostand KS, 1997, INFECT IMMUN, V65, P1
   Seo SJ, 2005, BIOMATERIALS, V26, P3607, DOI 10.1016/j.biomaterials.2004.09.025
   Sierakowski MR, 2007, J BRAZIL CHEM SOC, V18, P1017, DOI 10.1590/S0103-50532007000500021
   Sierakowski MR, 2002, CARBOHYD POLYM, V49, P167, DOI 10.1016/S0144-8617(01)00321-6
   Silva RA, 2007, INT J BIOL MACROMOL, V41, P404, DOI 10.1016/j.ijbiomac.2007.05.014
   SMIDSROD O, 1966, ACTA CHEM SCAND, V20, P1026, DOI 10.3891/acta.chem.scand.20-1026
   Spillmann D, 2001, BIOCHIMIE, V83, P811, DOI 10.1016/S0300-9084(01)01290-1
   Stokke BT, 2000, MACROMOLECULES, V33, P1853, DOI 10.1021/ma991559q
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Ueta RR, 2008, COLLOID SURFACE B, V61, P244, DOI 10.1016/j.colsurfb.2007.08.010
   ZAND R, 1971, P NATL ACAD SCI USA, V68, P2173, DOI 10.1073/pnas.68.9.2173
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 39
TC 15
Z9 15
U1 0
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2008
VL 66
IS 1
BP 45
EP 52
DI 10.1016/j.colsurfb.2008.05.013
PG 8
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 345GI
UT WOS:000258983900007
PM 18579349
DA 2020-11-10
ER

PT J
AU Neto, RJP
   Colares, JKB
   Fonseca, BAL
AF Neto, R. J. Pires
   Colares, J. K. B.
   Fonseca, B. A. L.
TI Evaluation of genotype resistance testing for salvage antiretroviral
   therapy at AIDS care centers from Ribeirao Preto, Sao Paulo, Brazil
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE HIV-1; antiretroviral therapy; salvage therapy; HIV-1 genotype
   resistance testing
ID RANDOMIZED CONTROLLED-TRIAL; HIV DRUG-RESISTANCE; ZIDOVUDINE RESISTANCE;
   MANAGEMENT; MUTATIONS; FAILURE; ADULTS; IMPACT
AB The availability of HIV-1 genotype resistance testing (GRT) to clinicians has been insufficiently studied outside randomized clinical trials. The present study evaluated the outcome of salvage antiretroviral therapy (ART) recommended by an expert physician based on GRT in a non-clinical trial setting in Ribeirao Preto, Brazil. A prospective, open, nonrandomized study evaluating easy access to GRT at six Brazilian AIDS Clinics was carried out. This cooperative study analyzed the efficacy of treatment recommended to patients whose salvage ART was guided by GRT with that of treatment with ART based only on previous ART history. A total of 112 patients with ART failure were included in the study, and 77 of them were submitted to GRT. The median CD4 cell count and viral load for these 77 patients at baseline were ( mean +/- SD) 252.1 +/- 157.4 cells/mu L and 4.60 +/- 0.5 log(10) HIV RNA copies/mL, respectively. The access time, i.e., the time elapsed between ordering the GRT and receiving the result was, on average, 71.9 +/- 37.3 days. The study results demonstrated that access to GRT followed by expert recommendations did not improve the time to persistent treatment failure when compared to conventional salvage ART. Access to GRT in this Brazilian community health care setting did not improve the long-term virologic outcomes of HIV-infected patients experiencing treatment failure. This result is probably related to the long time required to implement ART guided by GRT.
C1 [Neto, R. J. Pires; Colares, J. K. B.; Fonseca, B. A. L.] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Neto, R. J. Pires] Hosp Sao Jose Doencas Infecc, Secretaria Estado Saude, Fortaleza, Ceara, Brazil.
RP Fonseca, BAL (corresponding author), USP, FMRP, Dept Clin Med, Hosp Clin, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI Colares, Jeova Keny Baima/C-5257-2014; da Justa Pires Neto,
   Roberto/AAB-3425-2020; Fonseca, Benedito/F-3252-2012
OI Colares, Jeova Keny Baima/0000-0003-1367-6272; da Justa Pires Neto,
   Roberto/0000-0003-0291-9523; Fonseca, Benedito/0000-0003-3159-5687
CR Baxter JD, 2000, AIDS, V14, pF83, DOI 10.1097/00002030-200006160-00001
   Casseb J, 1999, AIDS PATIENT CARE ST, V13, P213, DOI 10.1089/apc.1999.13.213
   Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008
   Cohen CJ, 2002, AIDS, V16, P579, DOI 10.1097/00002030-200203080-00009
   DAQUILA RT, 1995, ANN INTERN MED, V122, P401, DOI 10.7326/0003-4819-122-6-199503150-00001
   *DHHS, 2006, GUID US ANT AG HIV 1
   Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2
   Green H, 2006, ANTIVIR THER, V11, P857
   Hirsch MS, 1998, JAMA-J AM MED ASSOC, V279, P1984, DOI 10.1001/jama.279.24.1984
   Hirsch MS, 2003, CLIN INFECT DIS, V37, P113, DOI 10.1086/375597
   JAPOUR AJ, 1995, J INFECT DIS, V171, P1172, DOI 10.1093/infdis/171.5.1172
   Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001
   Marins JRP, 2003, AIDS, V17, P1675, DOI 10.1097/00002030-200307250-00012
   Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008
   Miller V, 1998, J INFECT DIS, V177, P1521, DOI 10.1086/515304
   PIRES RJ, 2006, TRATADO CLIN MED, V3, P4198
   Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002
   Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010
   Wegner SA, 2004, CLIN INFECT DIS, V38, P723, DOI 10.1086/381266
   Zolopa AR, 1999, ANN INTERN MED, V131, P813, DOI 10.7326/0003-4819-131-11-199912070-00003
NR 20
TC 0
Z9 0
U1 0
U2 2
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN
PY 2008
VL 41
IS 6
BP 533
EP 538
DI 10.1590/S0100-879X2008005000013
PG 6
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 342EE
UT WOS:000258766600016
PM 18438592
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Nascimento, RT
   Gomes-Ruiz, AC
   Fonseca, BA
AF Nascimento, Renata T.
   Gomes-Ruiz, Alessandra C.
   Fonseca, Benedito A.
TI IL-5 levels and pain intensity correlated to high dengue 3 viral loads
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Nascimento, Renata T.; Gomes-Ruiz, Alessandra C.; Fonseca, Benedito A.] USP, FMRP, Ribeirao Preto, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 120
BP 36
EP 36
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758200121
DA 2020-11-10
ER

PT J
AU Gomes-Ruiz, AC
   Silva, BM
   Bonjardim, CA
   Fonseca, BA
AF Gomes-Ruiz, Alessandra C.
   Silva, Breno M.
   Bonjardim, Claudio A.
   Fonseca, Benedito A.
TI Inhibition of viral replication in human liver cells by short
   interfering RNA directed to 5 '-noncoding region of dengue-2 virus
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Gomes-Ruiz, Alessandra C.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [Silva, Breno M.; Bonjardim, Claudio A.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
RI Bonjardim, Claudio A/J-2601-2014
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 450
BP 129
EP 129
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758200448
DA 2020-11-10
ER

PT J
AU Lima, DM
   De Paula, SO
   Palma, PV
   Fonseca, BA
AF Lima, Danielle M.
   De Paula, Sergio O.
   Palma, Patricia V.
   Fonseca, Benedito A.
TI A bivalent DNA vaccine candidate against dengue-3 and dengue-4
   expressing the structural PRM/E proteins elicits cellular immune
   response and protects mice against lethal challenge
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Lima, Danielle M.; Palma, Patricia V.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
   [De Paula, Sergio O.] Univ Fed Vicosa, Vicosa, MG, Brazil.
RI Lima, Danielle/A-6108-2013; De Paula, Sergio/N-2609-2018
OI Lima, Danielle/0000-0003-2734-6768; De Paula, Sergio/0000-0002-2275-5768
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 757
BP 218
EP 218
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758201218
DA 2020-11-10
ER

PT J
AU Takahashi, P
   Fonseca, BA
AF Takahashi, Paula
   Fonseca, Benedito A.
TI Heavy precipitation in the beginning of the summer is associated to a
   smaller number of dengue cases in Ribeirao Preto, Sao Paulo State,
   Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Takahashi, Paula; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 761
BP 219
EP 219
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758201222
DA 2020-11-10
ER

PT J
AU Machado, PR
   Farias, KJ
   Castro, LA
   Fonseca, BA
AF Machado, Paula R.
   Farias, Kleber J.
   Castro, Luiza A.
   Fonseca, Benedito A.
TI Molecular epidemiology of human herpesvirus 8 in HIV-positive patients
   with Kaposi's sarcoma attended in Ribeirao Preto, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
CT 56th Annual Meeting of the
   American-Society-of-Tropical-Medicine-and-Hygiene
CY NOV 04-08, 2007
CL Philadelphia, PA
SP Amer Soc Trop Med & Hyg
C1 [Machado, Paula R.; Farias, Kleber J.; Castro, Luiza A.; Fonseca, Benedito A.] Univ Sao Paulo, Ribeirao Preto, SP, Brazil.
RI FARIAS, KLEBER/AAC-9815-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2007
VL 77
IS 5
SU S
MA 931
BP 266
EP 266
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 228UN
UT WOS:000250758201390
DA 2020-11-10
ER

PT J
AU Vanni, T
   Morejon, KM
   Santana, RC
   de Melo, L
   Ferrao, SBRL
   Amorim, AP
   Gaspar, GG
   Ponzi, CC
   Golin, NA
   Custodio, FL
   Marangoni, ATD
   Campos, CP
   Fonseca, BAL
AF Vanni, T.
   Morejon, K. M.
   Santana, R. C.
   de Melo, L.
   Ferrao, S. B. R. L.
   Amorim, A. P.
   Gaspar, G. G.
   Ponzi, C. C.
   Golin, N. A.
   Custodio, F. L.
   Marangoni, A. T. D.
   Campos, C. P., Jr.
   Fonseca, B. A. L.
TI Comparison of the effectiveness of initial combined antiretroviral
   therapy with nelfinavir or efavirenz at a university-based outpatient
   service in Brazil
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE AIDS; HIV; antiretroviral treatment; efavirenz; nelfinavir; highly
   active antiretroviral therapy
ID RESOURCE-POOR SETTINGS; HIV-INFECTION; PROTEASE-INHIBITOR; IMMUNOLOGICAL
   RESPONSE; RANDOMIZED-TRIALS; COHORT; ADULTS; ADHERENCE; RITONAVIR;
   REGIMENS
AB Since there are some concerns about the effectiveness of highly active antiretroviral therapy in developing countries, we compared the initial combination antiretroviral therapy with zidovudine and lamivudine plus either nelfinavir or efavirenz at a university-based outpatient service in Brazil. This was a retrospective comparative cohort study carried out in a tertiary level hospital. A total of 194 patients receiving either nelfinavir or efavirenz were identified through our electronic database search, but only 126 patients met the inclusion criteria. Patients were included if they were older than 18 years old, naive for antiretroviral therapy, and had at least 1 follow-up visit after starting the antiretroviral regimen. Fifty-one of the included patients were receiving a nelfinavir-based regimen and 75 an efavirenz-based regimen as outpatients. Antiretroviral therapy was prescribed to all patients according to current guidelines. By intention-to-treat (missing/switch = failure), after a 12-month period, 65% of the patients in the efavirenz group reached a viral load < 400 copies/mL compared to 41% of the patients in the nelfinavir group (P = 0.01). The mean CD4 cell count increase after a 12-month period was also greater in the efavirenz group (195 x 10(6) cells/ L) than in the nelfinavir group (119 x 10(6) cells/ L; P = 0.002). The efavirenz-based regimen was superior compared to the nelfinavir-based regimen. The low response rate in the nelfinavir group might be partially explained by the difficulty of using a regimen requiring a higher patient compliance (12 vs 3 pills a day) in a developing country.
C1 USP, FMRP, Dept Clin Med, Hosp Clin, BR-14049900 Ribeirao Preto, Brazil.
RP Fonseca, BAL (corresponding author), USP, FMRP, Dept Clin Med, Hosp Clin, Av Bandeirantes,3900, BR-14049900 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI de C Santana, Rodrigo/C-4429-2014; Vanni, Tazio P./B-7925-2018; Fonseca,
   Benedito/F-3252-2012
OI de C Santana, Rodrigo/0000-0002-5887-8663; Fonseca,
   Benedito/0000-0003-3159-5687
CR Albrecht MA, 2001, NEW ENGL J MED, V345, P398, DOI 10.1056/NEJM200108093450602
   Bartlett JA, 2006, AIDS, V20, P2051, DOI 10.1097/01.aids.0000247578.08449.ff
   Behrens G, 1999, AIDS, V13, pF63, DOI 10.1097/00002030-199907090-00001
   Erickson JW, 1999, AIDS, V13, pS189
   Haubrich RH, 1999, AIDS, V13, P1099, DOI 10.1097/00002030-199906180-00014
   HISCH MS, 2000, JAMA-J AM MED ASSOC, V283, P2417
   Hofer CB, 2004, JAIDS-J ACQ IMM DEF, V36, P967, DOI 10.1097/00126334-200408010-00011
   Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199
   Lucas GM, 2001, AIDS, V15, P1679, DOI 10.1097/00002030-200109070-00011
   Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002
   Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004
   Perez-Elias MJ, 2003, HIV CLIN TRIALS, V4, P391, DOI 10.1310/HVQX-7Q27-X4V1-GJA1
   Phillips AN, 1999, AIDS, V13, P2075, DOI 10.1097/00002030-199910220-00010
   Pulido F, 2004, JAIDS-J ACQ IMM DEF, V35, P343, DOI 10.1097/00126334-200404010-00003
   Robbins GK, 2003, NEW ENGL J MED, V349, P2293, DOI 10.1056/NEJMoa030264
   Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6
   Staszewski S, 1999, NEW ENGL J MED, V341, P1865, DOI 10.1056/NEJM199912163412501
   Stoll M, 2002, EUR J MED RES, V7, P463
   Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74
   Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002
   Walmsley S, 2002, NEW ENGL J MED, V346, P2039, DOI 10.1056/NEJMoa012354
   2001, BRAZILIAN GUIDELINE
NR 22
TC 2
Z9 2
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUL
PY 2007
VL 40
IS 7
BP 963
EP 969
DI 10.1590/S0100-879X2007000700011
PG 7
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 195KN
UT WOS:000248411200011
PM 17653450
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Farias, KJ
   Machado, PR
   Fonseca, BA
AF Farias, Kleber J.
   Machado, Paula R.
   Fonseca, Benedito A.
TI Chloroquine reduces dengue virus replication in vero cells but not in
   C6/36 cells, and partially protects mice against viral challenge
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Sch Med, Ribeirao Preto, Brazil.
RI FARIAS, KLEBER/AAC-9815-2019
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 115
BP 34
EP 35
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343900116
DA 2020-11-10
ER

PT J
AU Costa, EP
   Fonseca, BA
AF Costa, Emiliana P.
   Fonseca, Benedito A.
TI Dengue-2 virus almost abolish yellow fever virus replication in C6/36
   cells
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Ribeirao Preto, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 463
BP 135
EP 136
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343900464
DA 2020-11-10
ER

PT J
AU Nascimento, RT
   Fonseca, BA
AF Nascimento, Renata T.
   Fonseca, Benedito A.
TI Clinical and laboratorial evaluation of patients with suspected dengue-3
   infection in Ribeirao Preto, Sao Paulo, Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Ribeirao Preto, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD NOV
PY 2006
VL 75
IS 5
SU S
MA 471
BP 138
EP 138
PG 1
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 109XW
UT WOS:000242343900472
DA 2020-11-10
ER

PT J
AU Vanni, T
   Sprinz, E
   Machado, MW
   Santana, RDC
   Fonseca, BAL
   Schwartsmann, G
AF Vanni, Tazio
   Sprinz, Eduardo
   Machado, Marcelo Warlet
   Santana, Rodrigo de C.
   Fonseca, Benedito Antonio L.
   Schwartsmann, Gilberto
TI Systemic treatment of AIDS-related Kaposi sarcoma: Current status and
   perspectives
SO CANCER TREATMENT REVIEWS
LA English
DT Review
DE AIDS; Kaposi's sarcoma; treatment
ID ACTIVE ANTIRETROVIRAL THERAPY; PEGYLATED-LIPOSOMAL DOXORUBICIN;
   QUALITY-OF-LIFE; PHASE-II TRIAL; ORAL ETOPOSIDE; COMPLETE REGRESSION;
   ANTITUMOR-ACTIVITY; CANCER INCIDENCE; HIV; COMBINATION
AB Kaposi's sarcoma (KS) is the most frequent type of cancer in patients with Acquired Immune Deficiency Syndrome (AIDS). In the western world, its incidence decreased dramatically in the era of highly active anti-retroviral therapy (HAART). In contrast, the incidence of KS has been steadily climbing in parallel with the AIDS epidemic in Africa over the past 1015 years, being the most common cancer in adult men in countries like Uganda and Zimbabwe. AIDS-KS can be diagnosed at any stage of HIV infection, although it more commonly occurs in the setting of severe immune suppression, especially with an elevated viral toad. Up to now, AIDS-KS is stilt an incurable disease. Its clinical. course is variable, ranging from very indolent cases, requiring no or minimal therapy, to a rapidly progressive disease. Various local therapies are available to control small and asymptomatic lesions, while cytotoxic, immunological and biological therapies can be considered for more aggressive disease. The primary goal of therapy in most of the cases is to provide safe and effective palliation, in order to quality of Life. Optimal anti-retroviral therapy is a key component of AIDS-KS management. There are stilt many questions to be answered in the management of patients with AIDS-KS, such as (1) What are the therapeutic agents that should be used in this disease, and in which sequence? and (2) What are the benefits and risks expected with each treatment option? The aim of this review is to discuss the systemic management of AIDS-KS, with special focus on the above mentioned questions. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, Brazil.
RP Schwartsmann, G (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.
EM gschwartsmann@hcpa.ufrgs.br
RI sprinz, eduardo/V-7961-2019; Vanni, Tazio P./B-7925-2018; Schwartsmann,
   Gilberto/G-4256-2016; de C Santana, Rodrigo/C-4429-2014; Fonseca,
   Benedito/F-3252-2012
OI sprinz, eduardo/0000-0003-4343-8304; Schwartsmann,
   Gilberto/0000-0002-7850-1644; de C Santana, Rodrigo/0000-0002-5887-8663;
   Fonseca, Benedito/0000-0003-3159-5687
CR Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407
   Antoniou T, 2005, CLIN PHARMACOKINET, V44, P111, DOI 10.2165/00003088-200544020-00001
   Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
   BASSETT MT, 1995, INT J CANCER, V63, P9
   *BHIV WRIT COMM BE, 2001, GUID TREATM HIV INF, V2, P276
   Boivin G, 2000, AIDS, V14, P1907, DOI 10.1097/00002030-200009080-00004
   Bower M, 1999, AIDS, V13, P2105, DOI 10.1097/00002030-199910220-00014
   Cattelan AM, 1999, EUR J CANCER, V35, P1809, DOI 10.1016/S0959-8049(99)00161-6
   Cianfrocca M, 2002, J CLIN ONCOL, V20, P153, DOI 10.1200/JCO.20.1.153
   DEDICOAT M, 2004, COCHRANE LIB
   Dezube Bruce J, 2004, AIDS Read, V14, P236
   Echimane AK, 2000, CANCER, V89, P653, DOI 10.1002/1097-0142(20000801)89:3&lt;653::AID-CNCR22&gt;3.0.CO;2-Z
   Evans SR, 2002, J CLIN ONCOL, V20, P3236, DOI 10.1200/JCO.2002.12.038
   Gill J, 2002, JAIDS-J ACQ IMM DEF, V31, P384, DOI 10.1097/00126334-200212010-00003
   Gill PS, 1999, J CLIN ONCOL, V17, P1876, DOI 10.1200/JCO.1999.17.6.1876
   GILL PS, 1991, AM J MED, V90, P427, DOI 10.1016/0002-9343(91)80081-V
   Gill PS, 1996, J CLIN ONCOL, V14, P2353, DOI 10.1200/JCO.1996.14.8.2353
   Girard PM, 1996, AIDS, V10, P753, DOI 10.1097/00002030-199606001-00009
   Glesby MJ, 1996, J INFECT DIS, V173, P1477, DOI 10.1093/infdis/173.6.1477
   Grulich AE, 2001, AIDS, V15, P629, DOI 10.1097/00002030-200103300-00013
   Hammoud Z, 1998, CLIN INFECT DIS, V26, P1233, DOI 10.1086/598351
   Harris AH, 2002, SUPPORT CARE CANCER, V10, P486, DOI 10.1007/s00520-002-0363-2
   Hengge UR, 2002, LANCET INFECT DIS, V2, P281, DOI 10.1016/S1473-3099(02)00263-3
   Holkova B, 2001, J CLIN ONCOL, V19, P3848, DOI 10.1200/JCO.2001.19.18.3848
   Koon HB, 2005, J CLIN ONCOL, V23, P982, DOI 10.1200/JCO.2005.06.079
   KRIGEL RL, 1988, J BIOL RESP MODIF, V7, P359
   Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064
   Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085
   Krown SE, 2002, J INTERF CYTOK RES, V22, P295, DOI 10.1089/107999002753675712
   KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201
   Krown SE, 2001, CURR OPIN ONCOL, V13, P374, DOI 10.1097/00001622-200109000-00010
   LAUBENSTEIN LJ, 1984, J CLIN ONCOL, V2, P1115, DOI 10.1200/JCO.1984.2.10.1115
   Lebbe C, 1998, AIDS, V12, pF45, DOI 10.1097/00002030-199807000-00002
   Leitch H, 2003, HIV CLIN TRIALS, V4, P107
   Levine AM, 2003, LANCET ONCOL, V4, P576, DOI 10.1016/S1470-2045(03)01198-7
   Levine AM, 2001, EUR J CANCER, V37, P1288, DOI 10.1016/S0959-8049(01)00109-5
   Martin-Carbonero L, 2004, AIDS, V18, P1737, DOI 10.1097/01.aids.0000131385.60974.b9
   Martinelli C, 1998, AIDS, V12, P1717
   Mbulaiteye SM, 2003, HEMATOL ONCOL CLIN N, V17, P673, DOI 10.1016/S0889-8588(03)00048-0
   Miles SA, 2002, AIDS, V16, P421, DOI 10.1097/00002030-200202150-00014
   Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6
   MISUYASU R, 1997, P AN M AM SOC CLIN, V16, pA55
   Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309
   Murdaca G, 2002, AIDS, V16, P304, DOI 10.1097/00002030-200201250-00029
   Nasti G, 2003, CANCER-AM CANCER SOC, V98, P2440, DOI 10.1002/cncr.11816
   Nasti G, 2003, J CLIN ONCOL, V21, P2876, DOI 10.1200/JCO.2003.10.162
   Niehues T, 1999, AIDS, V13, P1148, DOI 10.1097/00002030-199906180-00026
   Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445
   Northfelt DW, 1997, J CLIN ONCOL, V15, P653, DOI 10.1200/JCO.1997.15.2.653
   Osoba D, 2001, CANCER INVEST, V19, P573, DOI 10.1081/CNV-100104284
   Paparizos VA, 2002, J ACQ IMMUN DEF SYND, V30, P257
   Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010
   Pati S, 2002, BLOOD, V99, P3771, DOI 10.1182/blood.V99.10.3771
   Pellet C, 2001, J INVEST DERMATOL, V117, P858, DOI 10.1046/j.0022-202x.2001.01465.x
   Postsmouth S., 2003, AIDS, V17, pF17
   Rosenthal E, 2002, AM J CLIN ONCOL-CANC, V25, P57, DOI 10.1097/00000421-200202000-00012
   SAVILLE MW, 1995, LANCET, V346, P26, DOI 10.1016/S0140-6736(95)92654-2
   Schwartsmann G, 1998, CANCER TREAT REV, V24, P415, DOI 10.1016/S0305-7372(98)90004-4
   Schwartsmann G, 1996, TUMORI, V82, P360
   Schwartsmann G, 1997, J CLIN ONCOL, V15, P2118, DOI 10.1200/JCO.1997.15.5.2118
   Sgadari C, 2000, J IMMUNOL, V165, P509, DOI 10.4049/jimmunol.165.1.509
   Sgadari C, 2003, LANCET ONCOL, V4, P537, DOI 10.1016/S1470-2045(03)01192-6
   SHEPHERD FA, 1988, CAN MED ASSOC J, V139, P635
   Sikora K, 1999, ANN ONCOL, V10, P385, DOI 10.1023/A:1008367822016
   SITAS F, 2000, J NATL CANC I MONOGR, V28, P1
   Sprinz E, 2001, AM J CLIN ONCOL-CANC, V24, P177, DOI 10.1097/00000421-200104000-00016
   Stebbing J, 2004, INT J CANCER, V108, P631, DOI 10.1002/ijc.11648
   Stewart S, 1998, J CLIN ONCOL, V16, P683, DOI 10.1200/JCO.1998.16.2.683
   Tirelli U, 2001, EUR J CANCER, V37, P1320, DOI 10.1016/S0959-8049(01)00106-X
   Tulpule A, 1998, J CLIN ONCOL, V16, P3369, DOI 10.1200/JCO.1998.16.10.3369
   Tulpule A, 2002, CANCER-AM CANCER SOC, V95, P147, DOI 10.1002/cncr.10634
   *US PAN CLIN PRACT, 2004, GUID US ANT AG HIV 1
   Von Roenn JH, 2003, HEMATOL ONCOL CLIN N, V17, P747, DOI 10.1016/S0889-8588(03)00043-1
   Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071
   Welles L, 1998, J CLIN ONCOL, V16, P1112, DOI 10.1200/JCO.1998.16.3.1112
   *WHO, 2003, WHO ESS DRUGS LIST
NR 76
TC 35
Z9 36
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0305-7372
EI 1532-1967
J9 CANCER TREAT REV
JI Cancer Treat. Rev.
PD OCT
PY 2006
VL 32
IS 6
BP 445
EP 455
DI 10.1016/j.ctrv.2006.06.001
PG 11
WC Oncology
SC Oncology
GA 094XB
UT WOS:000241271400005
PM 16860939
DA 2020-11-10
ER

PT J
AU Vanni, T
   Fonseca, BAL
   Polanczyk, CA
AF Vanni, Tazio
   Lopes Fonseca, Benedito Antonio
   Polanczyk, Carisi Anne
TI Cost-effectiveness analysis comparing chemotherapy regimens in the
   treatment of AIDS-related Kaposi's sarcoma in Brazil
SO HIV CLINICAL TRIALS
LA English
DT Article
DE chemotherapy; cost-effectiveness; Kaposi's sarcoma
ID ACTIVE ANTIRETROVIRAL THERAPY; PEGYLATED-LIPOSOMAL DOXORUBICIN; CANCER
   INCIDENCE; DAUNORUBICIN; HIV; VINCRISTINE; MANAGEMENT; BLEOMYCIN;
   SETTINGS; TRIALS
AB Background: Economic analyses of agents used in the treatment of AIDS and opportunistic diseases are particularly important in developing countries. Purpose: To analyze the cost-effectiveness of AIDS-related Kaposi's sarcoma (AIDS-KS) chemotherapy regimens in Brazil. Method: A decision-analysis model was developed, and effectiveness data were derived from randomized phase ill trials evaluating pegylated liposomal doxorubicin (PLD), liposomal daunorubicin (DNX), and the ABV regimen (doxorubicin, bleomycin, and vincristine). Resource data on direct medical costs were obtained from local sources. Results: The cost-effectiveness estimates (defined as average costs per patient who responds completely or partially) favored PLD (US $10,272/responder) in comparison to DNX (US $16,263/responder). Regarding cost-effectiveness, the ABV regimen that is widely used in developing countries had better results when compared to both PLD (US $1,268 vs. US $10,271) and DNX (US $1,268 vs. US $16,260). The incremental cost per additional responder of using PLD instead of ABV was US $20,990. Sensitivity analyses suggest that these results hold over a wide range of assumptions. Conclusion: ABV seems to be the most reasonable treatment option for AIDS-KS patients in resource-limited countries like Brazil.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil.
RP Polanczyk, CA (corresponding author), Hosp Clin Porto Alegre, Rua Ramiro Barcelos 2350,Sala 2225, BR-90035007 Porto Alegre, RS, Brazil.
EM cpolanczyk@hcpa.ufrgs.br
RI Vanni, Tazio P./B-7925-2018; Polanczyk, Carisi CAP/D-6208-2013; Fonseca,
   Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
CR Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
   BASSETT MT, 1995, INT J CANCER, V63, P9
   BENNETT CL, 1994, CANCER INVEST, V12, P336, DOI 10.3109/07357909409023033
   Bennett CL, 1998, J ACQ IMMUN DEF SYND, V18, P460, DOI 10.1097/00042560-199808150-00007
   Bower M, 1999, AIDS, V13, P2105, DOI 10.1097/00002030-199910220-00014
   *BRAZ MIN HLTH, 2004, HLTH PRIC DAT BANK 2
   DEDICOAT M, 2004, COCHRANE LIB
   Echimane AK, 2000, CANCER, V89, P653, DOI 10.1002/1097-0142(20000801)89:3&lt;653::AID-CNCR22&gt;3.0.CO;2-Z
   Gill PS, 1996, J CLIN ONCOL, V14, P2353, DOI 10.1200/JCO.1996.14.8.2353
   Grulich AE, 2001, AIDS, V15, P629, DOI 10.1097/00002030-200103300-00013
   Hjortsberg C, 1999, ACTA ONCOL, V38, P1063
   Krown SE, 2004, J CLIN ONCOL, V22, P399, DOI 10.1200/JCO.2004.08.064
   Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085
   KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201
   Leitch H, 2003, HIV CLIN TRIALS, V4, P107
   Levine AM, 2001, EUR J CANCER, V37, P1288, DOI 10.1016/S0959-8049(01)00109-5
   Lichtenegger H, 2004, ADV SPACE RES-SERIES, V33, P140, DOI 10.1016/j.asr.2003.07.018
   Lynen L, 2005, AIDS REV, V7, P13
   Martin-Carbonero L, 2004, AIDS, V18, P1737, DOI 10.1097/01.aids.0000131385.60974.b9
   Mbulaiteye SM, 2003, HEMATOL ONCOL CLIN N, V17, P673, DOI 10.1016/S0889-8588(03)00048-0
   Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309
   Northfelt DW, 1998, J CLIN ONCOL, V16, P2445, DOI 10.1200/JCO.1998.16.7.2445
   Olweny CLM, 2005, INT J CANCER, V113, P632, DOI 10.1002/ijc.20606
   Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010
   Rosenthal E, 2002, AM J CLIN ONCOL-CANC, V25, P57, DOI 10.1097/00000421-200202000-00012
   SITAS F, 2000, J NATL CANC I MONOGR, V28, P1
   SMITH TJ, 1993, JNCI-J NATL CANCER I, V85, P1460, DOI 10.1093/jnci/85.18.1460
   Stewart S, 1998, J CLIN ONCOL, V16, P683, DOI 10.1200/JCO.1998.16.2.683
   Teixeira PR, 2004, AIDS, V18, pS5, DOI 10.1097/00002030-200406003-00002
   Tulpule A, 1998, J CLIN ONCOL, V16, P3369, DOI 10.1200/JCO.1998.16.10.3369
   Von Roenn JH, 2003, HEMATOL ONCOL CLIN N, V17, P747, DOI 10.1016/S0889-8588(03)00043-1
   Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071
   Welte R, 2004, PHARMACOECONOMICS, V22, P857, DOI 10.2165/00019053-200422130-00004
NR 33
TC 11
Z9 12
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1528-4336
EI 1945-5771
J9 HIV CLIN TRIALS
JI HIV Clin. Trials
PD JUL-AUG
PY 2006
VL 7
IS 4
BP 194
EP 202
DI 10.1310/hct0704-194
PG 9
WC Infectious Diseases; Pharmacology & Pharmacy
SC Infectious Diseases; Pharmacology & Pharmacy
GA 098EQ
UT WOS:000241504200005
PM 17065031
DA 2020-11-10
ER

PT J
AU Neto, RJP
   Lima, DM
   de Paula, SO
   Lima, CM
   Rocco, IM
   Fonseca, BAL
AF Neto, RJP
   Lima, DM
   de Paula, SO
   Lima, CM
   Rocco, IM
   Fonseca, BAL
TI Molecular epidemiology of type 1 and 2 dengue viruses in Brazil from
   1988 to 2001
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE dengue virus; nucleotide sequence; E/NS1 region; molecular epidemiology;
   dengue fever; dengue hemorrhagic fever
ID HEMORRHAGIC-FEVER; EVOLUTION; SEQUENCES; GENE
AB Dengue is a mosquito-borne viral infection that in recent decades has become a major international public health concern. Epidemic dengue fever reemerged in Brazil in 1981. Since 1990 more than one dengue virus serotype has been circulating in this tropical country and increasing rates of dengue hemorrhagic fever and dengue shock syndrome have been detected every year. Some evidence supports the association between the introduction of a new serotype and/or genotype in a region and the appearance of dengue hemorrhagic fever. In order to study the evolutionary relationships and possible detection of the introduction of new dengue virus genotypes in Brazil in the last years, we analyzed partial nucleotide sequences of 52 Brazilian samples of both dengue type 1 and dengue type 2 isolated from 1988 to 2001 from highly endemic regions. A 240-nucleotide-long sequence from the envelope/nonstructural protein I gene junction was used for phylogenetic analysis. After comparing the nucleotide sequences originally obtained in this study to those previously studied by others, and analyzing the phylogenetic trees, we conclude that, after the initial introduction of the currently circulating dengue-1 and dengue-2 genotypes in Brazil, there has been no evidence of introduction of new genotypes since 1988. The increasing number of dengue hemorrhagic fever cases seen in Brazil in the last years is probably associated with secondary infections or with the introduction of new serotypes but not with the introduction of new genotypes.
C1 Univ Sao Paulo, FMRP, Dept Clin Med, Mol Virol Lab, BR-14049900 Ribeirao Preto, Brazil.
   Hosp Sao Jose Doencas Infecciosas, Secretaria Saude Estado Ceara, Fortaleza, Ceara, Brazil.
   Inst Adolfo Lutz Sao Paulo, Secao Arbovirus, Sao Paulo, Brazil.
RP Fonseca, BAL (corresponding author), Univ Sao Paulo, FMRP, Dept Clin Med, Mol Virol Lab, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; da Justa Pires Neto,
   Roberto/AAB-3425-2020; Lima, Danielle/A-6108-2013; Fonseca,
   Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; da Justa Pires Neto,
   Roberto/0000-0003-0291-9523; Lima, Danielle/0000-0003-2734-6768;
   Fonseca, Benedito/0000-0003-3159-5687
CR Aviles G, 2003, VIRUS RES, V98, P75, DOI 10.1016/j.virusres.2003.08.018
   Batista WC, 2001, VIRUS RES, V75, P35, DOI 10.1016/S0168-1702(01)00222-2
   CHUNGUE E, 1995, J GEN VIROL, V76, P1877, DOI 10.1099/0022-1317-76-7-1877
   DEUBEL V, 1993, ARCH VIROL, V129, P197, DOI 10.1007/BF01316895
   dos Santos CND, 2002, VIRUS RES, V90, P197, DOI 10.1016/S0168-1702(02)00180-6
   dos Santos FB, 2002, MEM I OSWALDO CRUZ, V97, P991, DOI 10.1590/S0074-02762002000700011
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Foster JE, 2004, VIROLOGY, V324, P48, DOI 10.1016/j.virol.2004.03.020
   Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Halstead Scott B., 1997, P23
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   IGARASHI A, 1985, ADV VIRUS RES, V30, P21, DOI 10.1016/S0065-3527(08)60447-9
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244
   Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279
   Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999
   LEWIS JA, 1993, VIROLOGY, V197, P216, DOI 10.1006/viro.1993.1582
   Lindenbach B.D., 2001, FIELDS VIROLOGY
   Mangada MNM, 1998, VIROLOGY, V244, P458, DOI 10.1006/viro.1998.9093
   McBride WJH, 2000, MICROBES INFECT, V2, P1041, DOI 10.1016/S1286-4579(00)01258-2
   Miagostovich Marize P., 2003, Rev. Inst. Med. trop. S. Paulo, V45, P17, DOI 10.1590/S0036-46652003000100004
   Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002
   Miagostovich MP, 1998, MEM I OSWALDO CRUZ, V93, P625, DOI 10.1590/S0074-02761998000500011
   NOGUEIRA RMR, 1993, EPIDEMIOL INFECT, V111, P163, DOI 10.1017/S0950268800056788
   NOGUEIRA RMR, 1991, MEM I OSWALDO CRUZ, V86, P269, DOI 10.1590/S0074-02761991000200018
   Pandey Basu Dev, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P266
   Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1
   Rico-Hesse R, 1998, AM J TROP MED HYG, V58, P96, DOI 10.4269/ajtmh.1998.58.96
   RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W
   RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504
   Rocco Iray Maria, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P55, DOI 10.1590/S0036-46652001000100011
   Rothman AL, 1999, VIROLOGY, V257, P1, DOI 10.1006/viro.1999.9656
   SCHATZMAYR HG, 2000, MEMORIAS I OSWALD S1, V95
   Shurtleff AC, 2001, VIROLOGY, V281, P75, DOI 10.1006/viro.2000.0748
   Uzcategui NY, 2001, J GEN VIROL, V82, P2945, DOI 10.1099/0022-1317-82-12-2945
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Watts J, 1999, LANCET, V354, P140, DOI 10.1016/S0140-6736(05)75281-8
NR 40
TC 17
Z9 17
U1 0
U2 4
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN
PY 2005
VL 38
IS 6
BP 843
EP 852
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 940EA
UT WOS:000230125300005
PM 15933777
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Rezende, REF
   Fonseca, BAL
   Ramalho, LNZ
   Zucoloto, S
   Pinho, JRR
   Bertolini, DA
   Martinelli, ALC
AF Rezende, REF
   Fonseca, BAL
   Ramalho, LNZ
   Zucoloto, S
   Pinho, JRR
   Bertolini, DA
   Martinelli, ALC
TI The precore mutation is associated with severity of liver damage in
   Brazilian patients with chronic hepatitis B
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE hepatitis B virus.; HBV genotypes; G1896A precore mutation; severity of
   liver disease; chronic hepatitis
ID FULMINANT-HEPATITIS; VIRUS INFECTION; CORE ANTIGEN; INTRAHEPATIC
   EXPRESSION; HISTOLOGICAL ACTIVITY; VIRAL REPLICATION; SEQUENCE-ANALYSIS;
   REGION DEFECTS; MUTANTS; GENOTYPES
AB Background: The clinical relevance of the G1896A precore mutation in chronic hepatitis B is still poorly understood.
   Objectives: To assess the frequency of G1896A precore mutation in Brazilian patients with chronic hepatitis B, as well as its relation to the viral genotype. serum HBV-DNA levels and liver damage.
   Study design: Fifty chronic hepatitis B patients (29 HBeAg-negative and 21 HBeAg-positive) were studied. HBV-DNA was quantified by the Amplicor HBV Monitor test and precore region and S gene were amplified and submitted to automatic sequencing. The histological activity index (HAI), degrees of hepatic fibrosis and distribution of core antigen (HBcAg) in hepatocytes were determined.
   Results: Precore mutation occurred in 1/21 (4.8%) HBeAg-positive patients and in 17/29 (58.6%) HBeAg-negative (P <0.0001). Genotype D was identified in 56.5%, genotype A in 41.3%, and genotype F in 2.2%. The frequency of genotypes D and A, as well as serum levels of ALT and HBV-DNA were similar in patients infected with wild type and with precore mutant. Patients infected with precore mutant presented a higher frequency of moderate/severe HAI (p: 0.03) and moderate/severe fibrosis and cirrhosis (p: 0.03) than those infected with wild type. There was no association between G1896A mutation and cytoplasmic expression of HBcAg.
   Conclusions: Precore mutation was frequent among Brazilian subjects with chronic hepatitis B and its presence was associated with greater severity of liver disease. (C) 2004 Elsevier B.V. All rights reserved.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, FMRP USP, BR-14048900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Pathol, FMRP USP, Ribeirao Preto, Brazil.
   Inst Adolfo Lutz Registro, Virol Branch, Sao Paulo, Brazil.
RP Rezende, REF (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Med, FMRP USP, BR-14048900 Ribeirao Preto, Brazil.
EM rosamarrezende@uol.com.br
RI Pinho, Joao R. R./G-2850-2012; Ramalho, Leandra/A-3983-2010; Fonseca,
   Benedito/F-3252-2012
OI Pinho, Joao R. R./0000-0003-3999-0489; Ramalho,
   Leandra/0000-0002-3486-5294; Fonseca, Benedito/0000-0003-3159-5687
CR BAHN A, 1995, J MED VIROL, V47, P336, DOI 10.1002/jmv.1890470408
   Ballard AL, 2000, J MED VIROL, V62, P463, DOI 10.1002/1096-9071(200012)62:4&lt;463::AID-JMV11&gt;3.0.CO;2-0
   BRUNETTO MR, 1990, J HEPATOL, V10, P258, DOI 10.1016/0168-8278(90)90062-V
   BRUNETTO MR, 1989, ITAL J GASTROENTEROL, V21, P151
   CARMAN WF, 1989, LANCET, V2, P588
   CHEN HS, 1992, J VIROL, V66, P5682, DOI 10.1128/JVI.66.9.5682-5684.1992
   CHU CM, 1995, GASTROENTEROLOGY, V109, P1926, DOI 10.1016/0016-5085(95)90760-2
   DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
   FATTOVICH G, 1991, GUT, V32, P294, DOI 10.1136/gut.32.3.294
   FRANCA STM, 1989, SCAND J GASTROENTERO, V24, P454, DOI 10.3109/00365528909093074
   Grandjacques C, 2000, J HEPATOL, V33, P430, DOI 10.1016/S0168-8278(00)80279-2
   Guidotti LG, 1996, J VIROL, V70, P7056, DOI 10.1128/JVI.70.10.7056-7061.1996
   Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834
   HADZIYANNIS SJ, 1995, VIRAL HEPATITIS REV, V1, P7
   Hunt CM, 2000, HEPATOLOGY, V31, P1037, DOI 10.1053/he.2000.6709
   KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511
   Knoll A, 1999, J MED VIROL, V59, P14, DOI 10.1002/(SICI)1096-9071(199909)59:1&lt;14::AID-JMV3&gt;3.0.CO;2-T
   KOSAKA Y, 1991, GASTROENTEROLOGY, V100, P1087, DOI 10.1016/0016-5085(91)90286-T
   Kramvis A, 1998, J HEPATOL, V28, P132, DOI 10.1016/S0168-8278(98)80212-2
   LAMBERTS C, 1993, J VIROL, V67, P3756, DOI 10.1128/JVI.67.7.3756-3762.1993
   LASKUS T, 1994, DIGEST DIS SCI, V39, P2000, DOI 10.1007/BF02088138
   LI JS, 1993, J VIROL, V67, P5402, DOI 10.1128/JVI.67.9.5402-5410.1993
   LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405
   Lindh M, 2000, J VIRAL HEPATITIS, V7, P258
   LINDH M, 1995, J INFECT DIS, V172, P1343, DOI 10.1093/infdis/172.5.1343
   Lindh M, 1999, J INFECT DIS, V179, P775, DOI 10.1086/314688
   LOK ASF, 1994, P NATL ACAD SCI USA, V91, P4077, DOI 10.1073/pnas.91.9.4077
   Mangia A, 1996, DIGEST DIS SCI, V41, P2447, DOI 10.1007/BF02100141
   Moraes MTB, 1996, ARCH VIROL, V141, P1767, DOI 10.1007/BF01718299
   NIITSUMA H, 1995, J MED VIROL, V46, P397, DOI 10.1002/jmv.1890460417
   OKAMOTO H, 1990, J VIROL, V64, P1298, DOI 10.1128/JVI.64.3.1298-1303.1990
   OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404
   Park YN, 1999, LIVER, V19, P199, DOI 10.1111/j.1478-3231.1999.tb00036.x
   Pinho J. R. R., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P515
   RAMALHO F, 1988, J HEPATOL, V7, P14, DOI 10.1016/S0168-8278(88)80502-6
   Rizzetto M, 2000, J MED VIROL, V61, P398, DOI 10.1002/1096-9071(200007)61:3&lt;398::AID-JMV20&gt;3.0.CO;2-E
   RodriguezFrias F, 1995, HEPATOLOGY, V22, P1641, DOI 10.1002/hep.1840220605
   SHAFRITZ DA, 1991, NEW ENGL J MED, V324, P1737, DOI 10.1056/NEJM199106133242411
   Sitnik R, 2000, HEPATOLOGY, V32, p578A
   Teles SA, 1999, ARTIF ORGANS, V23, P1074, DOI 10.1046/j.1525-1594.1999.06310.x
   TERAZAWA S, 1991, PEDIATR RES, V29, P5, DOI 10.1203/00006450-199101000-00002
   TURKASPA R, 1992, HEPATOLOGY, V16, P1338, DOI 10.1002/hep.1840160606
   Zuckerman AJ, 1999, J MED VIROL, V58, P193, DOI 10.1002/(SICI)1096-9071(199907)58:3&lt;193::AID-JMV1&gt;3.0.CO;2-X
NR 43
TC 33
Z9 38
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD JAN
PY 2005
VL 32
IS 1
BP 53
EP 59
DI 10.1016/j.jcv.2004.08.001
PG 7
WC Virology
SC Virology
GA 885XC
UT WOS:000226189600009
PM 15572007
DA 2020-11-10
ER

PT J
AU Carbonell, GV
   Amorim, CRN
   Furumura, MT
   Darini, ALC
   Fonseca, BAL
   Yano, T
AF Carbonell, GV
   Amorim, CRN
   Furumura, MT
   Darini, ALC
   Fonseca, BAL
   Yano, T
TI Biological activity of Serratia marcescens cytotoxi
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE cell culture; biological activity; Serratia marcescens; cytotoxin;
   virulence factors
ID INTENSIVE-CARE UNIT; OUTBREAK; INFECTION; CELLS
AB Serratia marcescens cytotoxin was purified to homogeneity by ionexchange chromatography on a DEAE Sepharose Fast Flow column, a followed by gel filtration chromatography on a Sephadex G100 column. The molecular mass of the cytotoxin was estimated to be about 50 kDa. Some biological properties of the cytotoxin were analyzed and compared with well-characterized toxins, such as VT1, VT2 and CNF from Escherichia coli and hemolysin produced by S. marcescens. The sensitivity of the cell lines CHO, HeLa, HEp-2, Vero, BHK-21, MA 104 and J774 to the cytotoxin was determined by the cell viability assay using neutral red. CHO and HEp-2 were highly sensitive, with massive cellular death after 1 h of treatment, followed by BHK-21, HeLa, Vero and J774 cells, while MA 104 was insensitive to the toxin. Cytotoxin induced morphological changes such as cell rounding with cytoplasmic retraction and nuclear compactation which were evident 15 min after the addition of cytotoxin. The cytotoxic assays show that 15 min of treatment with the cytotoxin induced irreversible intoxication of the cells, determined by loss of cell viability. Concentrations of 2 CD50 (0.56 mug/ml) of purified cytotoxin did not present any hemolytic activity, showing that the cytotoxin is distinct from S. marcescens hemolysin. Antisera prepared against S. marcescens cytotoxin did not neutralize the cytotoxic activity of VT1, VT2 or CNF toxin, indicating that these toxins do not share antigenic determinants with cytotoxin. Moreover, we did not detect gene sequences for any of these toxins in S. marcescens by PCR assay. These results suggest that S. marcescens cytotoxin is not related to any of these toxins from E. coli.
C1 UNICAMP, Dept Microbiol & Immunol, Inst Biol, BR-13083970 Campinas, SP, Brazil.
   Univ Sao Paulo, Dept Analises Clin Toxicol & Bromatol, Fac Ciencias Farmaceut, BR-14049 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.
RP Carbonell, GV (corresponding author), UNICAMP, Dept Microbiol & Immunol, Inst Biol, BR-13083970 Campinas, SP, Brazil.
RI Darini, Ana Lucia C/C-8127-2012; Fonseca, Benedito/F-3252-2012
OI Darini, Ana Lucia Costa/0000-0001-5433-926X; Fonseca,
   Benedito/0000-0003-3159-5687
CR Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008
   Blanco M, 1996, J MICROBIOL METH, V26, P95, DOI 10.1016/0167-7012(96)00900-1
   Blanco M, 1997, J CLIN MICROBIOL, V35, P2958, DOI 10.1128/JCM.35.11.2958-2963.1997
   Bosi C, 1996, J HOSP INFECT, V33, P217, DOI 10.1016/S0195-6701(96)90005-5
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carbonell GV, 1997, BRAZ J MED BIOL RES, V30, P1291, DOI 10.1590/S0100-879X1997001100005
   Carbonell GV, 1996, FEMS IMMUNOL MED MIC, V16, P299, DOI 10.1016/S0928-8244(96)00097-1
   CLEARY TG, 1985, INFECT IMMUN, V47, P335, DOI 10.1128/IAI.47.1.335-337.1985
   DAVIS BD, 1950, J BACTERIOL, V60, P17, DOI 10.1128/JB.60.1.17-28.1950
   GYLES CL, 1991, J MICROBIOLOGY, V38, P734
   Hertle R, 1999, INFECT IMMUN, V67, P817, DOI 10.1128/IAI.67.2.817-825.1999
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MACLEOD DL, 1991, INFECT IMMUN, V59, P1300, DOI 10.1128/IAI.59.4.1300-1306.1991
   MATSUMOTO K, 1984, J BACTERIOL, V157, P225, DOI 10.1128/JB.157.1.225-232.1984
   MELLO ML, 1980, PRATICAS BIOL CELULA, P71
   Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996
   Ojeniyi B., 1994, Journal of Veterinary Medicine Series B, V41, P49, DOI 10.1111/j.1439-0450.1994.tb00205.x
   Parreira VR, 1998, VET MICROBIOL, V62, P111, DOI 10.1016/S0378-1135(98)00197-7
   vanOgtrop ML, 1997, J HOSP INFECT, V36, P95, DOI 10.1016/S0195-6701(97)90115-8
NR 19
TC 6
Z9 8
U1 0
U2 3
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAR
PY 2003
VL 36
IS 3
BP 351
EP 359
DI 10.1590/S0100-879X2003000300010
PG 9
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 661ZJ
UT WOS:000181920300010
PM 12640500
OA DOAJ Gold, Green Published
DA 2020-11-10
ER

PT J
AU De Paula, SO
   Neto, RJP
   Correa, JACT
   Assumpcao, SR
   Costa, MLS
   Lima, DM
   Fonseca, BAL
AF De Paula, SO
   Neto, RJP
   Correa, JACT
   Assumpcao, SR
   Costa, MLS
   Lima, DM
   Fonseca, BAL
TI The use of reverse transcription-polymerase chain reaction (RT-PCR) for
   the rapid detection and identification of dengue virus in an endemic
   region: a validation study
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE dengue; diagnosis; polymerase chain reaction; validation study; Brazil
ID DIAGNOSIS; FEVER
AB Dengue is the most important arboviral disease worldwide. Dengue diagnosis is usually made by serology, but serological techniques do not identify the infecting strain, and are only useful late in the course of infection. Several reverse transcription-polymerase chain reaction (RT-PCR) protocols have been described for dengue diagnosis but none of them has been used on a regular basis. We conducted a validation study of PCR-based diagnosis in an area (in Brazil) where dengue-1 virus has been circulating at a low incidence rate. Viral detection by RT-PCR was evaluated using the sera of 253 patients with clinical diagnosis of dengue, and the results were compared to those obtained by IgM. capture enzyme-linked immunosorbent assay (MAC-ELISA) and virus isolation. Out of 75 IgM-positive samples, 17 were RT-PCR positive, and only 2 were positive for virus isolation. Through enzymatic digestion of PCR amplicons, we were able to differentiate the 2 dengue serotypes circulating in Brazil (dengue-1 and dengue-2), and to determine that dengue-1 was the virus responsible for the infections. We show with this study that RT-PCR is more sensitive than virus isolation on clinical samples and allows for a rapid detection of dengue infections and for a straightforward identification of the circulating serotype.
C1 Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Sao Paulo, Sch Med Ribeirao Preto, Programme Grad Studies Appl Microbiol & Immunol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Inst Adolfo Lutz Registro, Ribeirao Preto, SP, Brazil.
   Div Epidem Surveillance Municipal Dist Ribeirao P, Ribeirao Preto, SP, Brazil.
RP Fonseca, BAL (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Mol Virol Lab, Avenida Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM baldfons@fmrp.usp.br
RI De Paula, Sergio/N-2609-2018; da Justa Pires Neto,
   Roberto/AAB-3425-2020; Lima, Danielle/A-6108-2013; Fonseca,
   Benedito/F-3252-2012
OI De Paula, Sergio/0000-0002-2275-5768; da Justa Pires Neto,
   Roberto/0000-0003-0291-9523; Lima, Danielle/0000-0003-2734-6768;
   Fonseca, Benedito/0000-0003-3159-5687
CR CHAN SY, 1994, J VIROL METHODS, V49, P315, DOI 10.1016/0166-0934(94)90146-5
   FULOP L, 1993, J VIROL METHODS, V44, P179, DOI 10.1016/0166-0934(93)90053-T
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   GUBLER DJ, 1988, P INT S YELL FEV DEN, P291
   Guzman MG, 1996, CLIN DIAGN LAB IMMUN, V3, P621
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Harris E, 1999, VIROLOGY, V253, P86, DOI 10.1006/viro.1998.9481
   HENCHAL EA, 1991, AM J TROP MED HYG, V45, P418, DOI 10.4269/ajtmh.1991.45.418
   Miagostovich MP, 2000, J CLIN MICROBIOL, V38, P1286, DOI 10.1128/JCM.38.3.1286-1289.2000
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Suk-Yin Chan, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P258
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   VORNDAM V, 1994, ARCH VIROL, V136, P191, DOI 10.1007/BF01538828
   VORNDAM V, 1994, J VIROL METHODS, V48, P237, DOI 10.1016/0166-0934(94)90122-8
   WENGLER G, 1991, ARCH VIROLOGY S2, V136, P230
   WHO, 1998, DENG HAEM FEV DIAGN
   1994, SCI PUBLICATION, V548
NR 19
TC 22
Z9 24
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAY-JUN
PY 2002
VL 96
IS 3
BP 266
EP 269
DI 10.1016/S0035-9203(02)90094-5
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA 579DV
UT WOS:000177161900008
PM 12174774
DA 2020-11-10
ER

PT J
AU Netto, MVP
   Fonseca, BAL
   Dantas, M
   Saber, LTS
   Castro, MCR
   Ferraz, AS
AF Netto, MVP
   Fonseca, BAL
   Dantas, M
   Saber, LTS
   Castro, MCR
   Ferraz, AS
TI Granzyme B, FAS-ligand and perforin expression during acute cellular
   rejection episodes after kidney transplantation: Comparison between
   blood and renal aspirates
SO TRANSPLANTATION PROCEEDINGS
LA English
DT Article; Proceedings Paper
CT 7th Congress of the Brazilian-Organ-Transplant-Association (ABTO)
CY MAR 28-31, 2001
CL VITORIA, BRAZIL
SP Brazilian Organ Transplant Assoc
ID ALLOGRAFT-REJECTION; GENE-EXPRESSION; ANTIGEN EXPRESSION; APOPTOSIS;
   LYMPHOCYTES; TRANSCRIPTS; DIAGNOSIS
C1 Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp, Dept Internal Med, BR-14048900 Ribeirao Preto, Brazil.
   Univ Sao Paulo, Sao Paulo Med Sch, Renal Transplantat Unit, Sao Paulo, Brazil.
RP Netto, MVP (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Renal Transplant Unit, BR-14048900 Ribeirao Preto, Brazil.
RI de castro, maria cristina ribeiro/B-6648-2009; Dantas,
   Marcio/B-9838-2013; Fonseca, Benedito/F-3252-2012
OI de castro, maria cristina ribeiro/0000-0002-6731-8369; Dantas,
   Marcio/0000-0001-8515-6423; Fonseca, Benedito/0000-0003-3159-5687
CR Barth C, 1998, TRANSPLANT P, V30, P2347, DOI 10.1016/S0041-1345(98)00647-2
   CHEIGH JS, 1983, NEPHRON, V35, P6, DOI 10.1159/000183036
   Colvin RB, 1997, J AM SOC NEPHROL, V8, P1930
   GJERTSON DW, 1991, NEW ENGL J MED, V324, P1032, DOI 10.1056/NEJM199104113241505
   HAYRY P, 1981, SCAND J IMMUNOL, V13, P87, DOI 10.1111/j.1365-3083.1981.tb00114.x
   HAYRY P, 1984, TRANSPLANTATION, V38, P1
   HELDERMAN JH, 1988, KIDNEY INT, V34, P376, DOI 10.1038/ki.1988.191
   JEYARAJAH DR, 1995, TRANSPLANT P, V27, P887
   Kato S, 1997, PATHOL INT, V47, P230, DOI 10.1111/j.1440-1827.1997.tb04485.x
   LARSE CP, 1995, TRANSPLANTATION, V15, P221
   LEIDTKE W, 1994, PCR METH APPL, V3, P185
   LIPMAN ML, 1992, TRANSPLANTATION, V53, P73, DOI 10.1097/00007890-199201000-00014
   LIPMAN ML, 1994, J IMMUNOL, V152, P5120
   MASSON D, 1985, J BIOL CHEM, V260, P9069
   MATSUNO T, 1998, TRANSPLANT P, V66, P1067
   Pascoe MD, 2000, TRANSPLANTATION, V69, P2547, DOI 10.1097/00007890-200006270-00013
   Pavlakis M, 1996, TRANSPL P, V28, P2019
   Porter CJ, 2000, TRANSPLANTATION, V69, P1091, DOI 10.1097/00007890-200003270-00012
   RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594
   RUKAVINA D, 1995, AM J REPROD IMMUNOL, V33, P394, DOI 10.1111/j.1600-0897.1995.tb00908.x
   Saad R, 1997, TRANSPLANTATION, V64, P992, DOI 10.1097/00007890-199710150-00010
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   Sharma VK, 1996, TRANSPLANTATION, V62, P1860, DOI 10.1097/00007890-199612270-00031
   Sharma VK, 1998, TRANSPL P, V30, P2364, DOI 10.1016/S0041-1345(98)00656-3
   SMYTH MJ, 1995, IMMUNOL TODAY, V16, P202, DOI 10.1016/0167-5699(95)80122-7
   Strehlau J, 1997, P NATL ACAD SCI USA, V94, P695, DOI 10.1073/pnas.94.2.695
   SUDA T, 1994, J EXP MED, V179, P873, DOI 10.1084/jem.179.3.873
   SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L
   Vasconcellos LM, 1998, TRANSPLANTATION, V66, P562, DOI 10.1097/00007890-199809150-00002
   Wang JD, 1997, J INTERF CYTOK RES, V17, P369, DOI 10.1089/jir.1997.17.369
NR 30
TC 29
Z9 34
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0041-1345
J9 TRANSPLANT P
JI Transplant. Proc.
PD MAR
PY 2002
VL 34
IS 2
BP 476
EP 478
AR PII S0041-1345(02)02601-5
DI 10.1016/S0041-1345(02)02601-5
PG 3
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 553LB
UT WOS:000175675700017
PM 12009596
DA 2020-11-10
ER

PT J
AU Rezende, RE
   Pinho, JR
   Bertolini, DA
   Secaf, M
   Ramalho, LN
   Zucoloto, S
   Rodrigues, SS
   Fonseca, BA
   Martinelli, AL
AF Rezende, RE
   Pinho, JR
   Bertolini, DA
   Secaf, M
   Ramalho, LN
   Zucoloto, S
   Rodrigues, SS
   Fonseca, BA
   Martinelli, AL
TI Precore mutation and its relation with HBV-DNA levels, viral genotypes
   and liver damage in Brazilian patients with chronic hepatitis B virus
   (HBV) infection.
SO HEPATOLOGY
LA English
DT Meeting Abstract
C1 Univ Sao Paulo, Sch Med, BR-14049 Ribeirao Preto, Brazil.
   Inst Adolfo Lutz Registro, Sao Paulo, Brazil.
RI Pinho, Joao R. R./G-2850-2012
OI Pinho, Joao R. R./0000-0003-3999-0489
NR 0
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO
PI PHILADELPHIA
PA INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399 USA
SN 0270-9139
J9 HEPATOLOGY
JI Hepatology
PD OCT
PY 2001
VL 34
IS 4
SU S
MA 1765
BP 613A
EP 613A
PN 2
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 476KE
UT WOS:000171224701755
DA 2020-11-10
ER

PT J
AU Carbonell, GV
   Della Colleta, HHM
   Yano, T
   Darini, ALC
   Levy, CE
   Fonseca, BAL
AF Carbonell, GV
   Della Colleta, HHM
   Yano, T
   Darini, ALC
   Levy, CE
   Fonseca, BAL
TI Clinical relevance and virulence factors of pigmented Serratia
   marcescens
SO FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
LA English
DT Article
DE nosocomial infection; serotyping; virulence factor; pigmented Serratia
   marcescens
ID ESCHERICHIA-COLI; O-SEROTYPE; K-SEROTYPE; PATHOGENICITY; RESISTANCE;
   CELLS
AB Pigmented Serratia marcescens isolated in a Brazilian hospital were studied with respect to frequency of isolation, serotyping, antibiotic resistance and virulence factors. The serotype most frequent was O6:K14(53%) and all isolates were resistant to ampicillin, cephalothin and tetracycline. The majority of the isolates (92%) were resistant to the action of human serum and all produced cytotoxins on Vero, CHO, HEp-2 and Mt La cells. These isolates were virulent for mice (LD50 = 10(7) bacteria ml(-1)) and showed virulence factors, but were isolated with low frequency (3.4%) and caused infection in only 31% of cases. Analysis of serotyping, phage typing and chromosomal DNA revealed at least 13 unrelated strains among pigmented S. marcescens. In conclusion, this work describes a low frequency of isolation of pigmented S. marcescens from clinical specimens, indicating that non-pigmented strains are clinically more significant. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
C1 Univ Estadual Campinas, Dept Microbiol & Imunol, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Anal Clin Toxciol & Bromatol, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Ciencias Farmaceut, Disciplina Microbiol, Sao Paulo, Brazil.
   Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Sao Paulo, Brazil.
RP Yano, T (corresponding author), Univ Estadual Campinas, Dept Microbiol & Imunol, Sao Paulo, Brazil.
RI Levy, Carlos/AAN-7226-2020; Darini, Ana Lucia C/C-8127-2012; Levy,
   Carlos/L-2116-2013; Fonseca, Benedito/F-3252-2012
OI Levy, Carlos/0000-0002-4862-8900; Fonseca, Benedito/0000-0003-3159-5687
CR Aucken HM, 1998, J MED MICROBIOL, V47, P1105, DOI 10.1099/00222615-47-12-1105
   Aucken HM, 1998, J MED MICROBIOL, V47, P1097, DOI 10.1099/00222615-47-12-1097
   BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
   Carbonell GV, 1997, BRAZ J MED BIOL RES, V30, P1291, DOI 10.1590/S0100-879X1997001100005
   CARBONELL GV, 1992, REV MICROBIOL, V23, P72
   Darini Ana Lucia Da Costa, 1995, Revista Latinoamericana de Microbiologia, V37, P217
   FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989
   GARGALLOVIOLA D, 1989, J CLIN MICROBIOL, V27, P860, DOI 10.1128/JCM.27.5.860-868.1989
   Gautom RK, 1997, J CLIN MICROBIOL, V35, P2977, DOI 10.1128/JCM.35.11.2977-2980.1997
   Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903
   KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981
   KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977
   PITT TL, 1980, J HYG-CAMBRIDGE, V84, P269, DOI 10.1017/S0022172400026772
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   WILFERT JN, 1970, APPL MICROBIOL, V19, P345, DOI 10.1128/AEM.19.2.345-352.1970
   WILLIAMS RP, 1971, J BACTERIOL, V106, P438, DOI 10.1128/JB.106.2.438-443.1971
   WILLIAMS RP, 1971, J BACTERIOL, V106, P444, DOI 10.1128/JB.106.2.444-448.1971
   Williams RP, 1973, APPL MICROBIOL, V116, P259
NR 18
TC 26
Z9 27
U1 0
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-8244
J9 FEMS IMMUNOL MED MIC
JI FEMS Immunol. Med. Microbiol.
PD JUN
PY 2000
VL 28
IS 2
BP 143
EP 149
DI 10.1016/S0928-8244(00)00146-2
PG 7
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 312ZJ
UT WOS:000086973600008
PM 10799805
OA Bronze
DA 2020-11-10
ER

PT J
AU Bollela, VR
   Sato, DN
   Fonseca, BAL
AF Bollela, VR
   Sato, DN
   Fonseca, BAL
TI McFarland nephelometer as a simple method to estimate the sensitivity of
   the polymerase chain reaction using Mycobacterium tuberculosis as a
   research tool
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE tuberculosis; PCR
ID AMPLIFICATION; DNA; DIAGNOSIS; SPECIMENS
AB Polymerase chain reaction (PCR) has been widely investigated for the diagnosis of tuberculosis. However, before this technique is applied on clinical samples, it needs to be well standardized. We describe the use of McFarland nephelometer, a very simple approach to determine microorganism concentration in solution, for PCR standardization and DNA quantitation, using Mycobacterium tuberculosis as a model. Tuberculosis is an extremely important disease for the public health system in developing countries and, with the advent of AIDS, it has also become an important public health problem in developed countries. Using Mycobacterium tuberculosis as a research model, we were able to detect 3 M. tuberculosis genomes using the McFarland nephelometer to assess micobacterial concentration. We have shown here that McFarland nephelometer is an easy and reliable procedure to determine PCR sensitivity at lower costs.
C1 USP, FMRP, Dept Clin Med, BR-14049900 Ribeirao Preto, Brazil.
   Inst Adolfo Lutz de Ribeirao Preto, Ribeirao Preto, Brazil.
RP Fonseca, BAL (corresponding author), USP, FMRP, Dept Clin Med, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, Brazil.
RI Bollela, Valdes Roberto/F-9182-2014; Fonseca, Benedito/F-3252-2012
OI Bollela, Valdes Roberto/0000-0002-8221-4701; Fonseca,
   Benedito/0000-0003-3159-5687
CR BRISSONNOEL A, 1989, LANCET, V2, P1069
   COUSINS DV, 1992, J CLIN MICROBIOL, V30, P255, DOI 10.1128/JCM.30.1.255-258.1992
   EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977
   FORBES BA, 1993, J CLIN MICROBIOL, V31, P1688, DOI 10.1128/JCM.31.7.1688-1694.1993
   KOCAGOZ T, 1993, J CLIN MICROBIOL, V31, P1435
   MCFARLAND J, 1907, JAMA-J AM MED ASSOC, V14, P1176
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SCHLUGER NW, 1994, CHEST, V105, P1116, DOI 10.1378/chest.105.4.1116
   SHAH JS, 1995, J CLIN MICROBIOL, V33, P1435, DOI 10.1128/JCM.33.6.1435-1441.1995
   Spargo CA, 1996, MOL CELL PROBE, V10, P247, DOI 10.1006/mcpr.1996.0034
   WOLINSKY E, 1994, CLIN INFECT DIS, V19, P396, DOI 10.1093/clinids/19.3.396
NR 11
TC 12
Z9 13
U1 0
U2 1
PU ASSOC BRAS DIVULG CIENTIFICA
PI SAO PAULO
PA FACULDADE MEDICINA, SALA 21, 14049 RIBEIRAO PRETO, SAO PAULO, BRAZIL
SN 0100-879X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD SEP
PY 1999
VL 32
IS 9
BP 1073
EP 1076
DI 10.1590/S0100-879X1999000900003
PG 4
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 241ED
UT WOS:000082869000003
PM 10464381
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Bollela, VR
   Sato, DN
   Fonseca, BAL
AF Bollela, VR
   Sato, DN
   Fonseca, BAL
TI Problems in the standardization of the polymerase chain reaction for the
   diagnosis of pulmonary tuberculosis
SO REVISTA DE SAUDE PUBLICA
LA Portuguese
DT Article
DE tuberculosis, pulmonary diagnostic; polymerase chain reaction;
   mycobacterium tuberculosis
ID MYCOBACTERIUM-TUBERCULOSIS; AMPLIFICATION
AB Introduction
   The recent increase in the number of tuberculosis cases has called the world's attention once again to a perennial health problem, especially prevalent in developing countries. The time elapsed between the diagnosis and the institution of therapy is an obstacle to tuberculosis control and there is an urgent need for the development of techniques for the disease's rapid diagnosis. To achieve this goal molecular biology techniques have been exhaustively investigated. This work describes the use of a polymerase chain reaction for rapid diagnosis of tuberculosis in a developing country. The sensitivity and specificity of this technique is compared to standard techniques used in the microbiology laboratory.
   Methods
   This study was undertaken in Ribeirao Preto, S. Paulo State, Brazil. Forty-two sputum samples from suspected cases of tuberculosis attending the municipal health care centers were sent to the microbiology.laboratory. The samples were processed for the detection of Mycobacterium tuberculosis by acid-fast bacilli determination, culture in Lowenstein-Jensen medium, and by a polymerase chain reaction that amplified a fragment of 123 bare pairs of the Mycobacterium tuberculosis genome.
   Results
   Of the forty-two samples studied one was contaminated and excluded from the study, ten were culture positive, ten were positive for the presence of acid-fast bacilli, and sixteen were polymerase chain reaction positive. The sensitivity and specificity of this technique were 90% and 81%, respectively.
   Conclusions
   The polymerase chain reaction presented a sensitivity comparable to the? culture and the whole procedure took only one day to complete. The results presented here make it a strong candidate for rapid diagnosis of tuberculosis in clinical settings making it possible to begin the specific therapy early in the course of the disease. However, standardization of the technique is necessary, and the correlation with clinical findings is of paramount importance due to the high sensitivity of this technique.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, Ribeirao Preto, SP, Brazil.
   Inst Adolfo Lutz Ribeirao Preto, Ribeirao Preto, SP, Brazil.
RP Fonseca, BAL (corresponding author), Av Bandeirantes,3900 Monte Alegre, BR-14049900 Ribeirao Preto, SP, Brazil.
RI Bollela, Valdes Roberto/F-9182-2014; Fonseca, Benedito/F-3252-2012
OI Bollela, Valdes Roberto/0000-0002-8221-4701; Fonseca,
   Benedito/0000-0003-3159-5687
CR BARNES PF, 1993, ANN INTERN MED, V119, P400, DOI 10.7326/0003-4819-119-5-199309010-00009
   BATES JH, 1979, CHEST, V76, P757, DOI 10.1378/chest.76.6.757
   Cartuyvels R, 1996, J CLIN MICROBIOL, V34, P2001, DOI 10.1128/JCM.34.8.2001-2003.1996
   EISENACH KD, 1990, J INFECT DIS, V161, P977, DOI 10.1093/infdis/161.5.977
   FONSECA BAL, 1997, BRAZ J INFECT DIS, V1, P57
   Forbes BA, 1997, IMMUNOL INVEST, V26, P105, DOI 10.3109/08820139709048919
   Garcia Garcia M L, 1994, Bol Oficina Sanit Panam, V116, P546
   KOCAGOZ T, 1993, J CLIN MICROBIOL, V31, P1435
   KONEMAN EW, 1992, MYCOBACTERIA, P703
   KRITSKI AL, 1997, J PNEUMOL, V23, P33
   *MIN SAUD, 1996, B EP AIDS
   Otal I, 1997, J CLIN MICROBIOL, V35, P273, DOI 10.1128/JCM.35.1.273-277.1997
   *SECR EST SAUD SAO, 1995, TUB UM EM MUND
   SNIDER DE, 1994, J INFECT DIS, V169, P1189, DOI 10.1093/infdis/169.6.1189
NR 14
TC 13
Z9 14
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01255 SAO PAULO, BRAZIL
SN 0034-8910
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN
PY 1999
VL 33
IS 3
BP 281
EP 286
DI 10.1590/S0034-89101999000300009
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 229LX
UT WOS:000082197000009
PM 10457001
OA DOAJ Gold
DA 2020-11-10
ER

PT J
AU Carbonell, GV
   Fonseca, BAL
   Figueiredo, LTM
   Darini, ALC
   Yanaguita, RM
AF Carbonell, GV
   Fonseca, BAL
   Figueiredo, LTM
   Darini, ALC
   Yanaguita, RM
TI Culture conditions affect cytotoxin production by Serratia marcescens
SO FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
LA English
DT Article
DE cytotoxin production; culture conditions; Serratia marcescens
ID ESCHERICHIA-COLI; CLOSTRIDIUM-DIFFICILE; TOXIN PRODUCTION; VIRULENCE
   GENES; EXOTOXIN-A; IRON; TEMPERATURE; GROWTH; PATHOGENICITY; RESISTANCE
AB Cytotoxins have been implicated in the pathogenesis of bacterial infections. In this study, the influence of different culture conditions was evaluated on cytotoxin production by Serratia marcescens. Parameters such as culture media, incubation temperature, starting pH of culture medium, aeration, anaerobiosis, carbon sources, iron concentration in the culture media, and release of cell-bound toxin by polymyxin B were investigated. The data suggest that this cytotoxin is predominantly extracellular and is not induced by iron limitation. Aerobic culture with shaking resulted in higher cytotoxicity than static aerobic or anaerobic culture. Bacteria grown in glucose, sucrose or galactose were more cytotoxic than those grown in inositol or maltose. The culture conditions that were identified as optimal for cytotoxin production by Serratia marcescens were incubation temperature ranging from 30 to 37 degrees C, in medium adjusted to pH 8.5, with shaking. This work will contribute to further studies on the identification of this cytotoxic activity.
C1 USP,FAC CIENCIAS FARMACEUT RIBEIRAO PRETO,DEPT ANAL CLIN TOXICOL & BROMATOL,RIBEIRAO PRET,SP,BRAZIL.
   USP,INST CIENCIAS BIOMED 2,RIBEIRAO PRET,SP,BRAZIL.
   USP,FAC MED RIBEIRAO PRETO,DEPT CLIN MED,RIBEIRAO PRET,SP,BRAZIL.
RI Darini, Ana Lucia C/C-8127-2012; Figueiredo, Luiz T/E-3702-2012;
   Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
CR Bizette G A, 1995, J La State Med Soc, V147, P64
   BJORN MJ, 1978, INFECT IMMUN, V19, P785, DOI 10.1128/IAI.19.3.785-791.1978
   Borenfreund E., 1984, J TISSUE CULTURE MET, V9, P7, DOI DOI 10.1007/BF01666038
   CAMPBELL JR, 1992, PEDIATR INFECT DIS J, V11, P881, DOI 10.1097/00006454-199210000-00015
   CARBONELL GV, 1992, REV MICROBIOL, V23, P72
   CARBONELL GV, 1992, BRAZ J MED BIOL RES, V25, P1
   CASTANEDAAGULLO M, 1956, J GEN PHYSIOL, V39, P369, DOI 10.1085/jgp.39.3.369
   DONOHUEROLFE A, 1983, INFECT IMMUN, V39, P270, DOI 10.1128/IAI.39.1.270-274.1983
   FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989
   FRANK DW, 1994, METHOD ENZYMOL, V235, P502
   FRANK DW, 1989, J BACTERIOL, V170, P4477
   GILLIGAN PH, 1979, INFECT IMMUN, V23, P99, DOI 10.1128/IAI.23.1.99-107.1979
   HASLAM SC, 1986, J MED MICROBIOL, V21, P293, DOI 10.1099/00222615-21-4-293
   Hernandez-Delgadillo Ricardo, 1994, Revista Latinoamericana de Microbiologia, V36, P93
   JEPSEN PK, 1987, APPL ENVIRON MICROB, V53, P2593, DOI 10.1128/AEM.53.10.2593-2596.1987
   KARMALI MA, 1985, J CLIN MICROBIOL, V22, P614, DOI 10.1128/JCM.22.4.614-619.1985
   KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775, DOI 10.1128/IAI.18.3.775-779.1977
   LITWIN CM, 1993, CLIN MICROBIOL REV, V6, P137, DOI 10.1128/CMR.6.2.137-149.1993
   MACLEOD DL, 1989, CAN J MICROBIOL, V35, P623, DOI 10.1139/m89-100
   MAEDA H, 1995, METHOD ENZYMOL, V248, P395
   MAHONY DE, 1989, APPL ENVIRON MICROB, V55, P2141, DOI 10.1128/AEM.55.9.2141-2143.1989
   MATSUMOTO K, 1984, J BACTERIOL, V157, P225, DOI 10.1128/JB.157.1.225-232.1984
   MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984
   McNaughton M, 1995, Can J Infect Control, V10, P7
   MELTZ DJ, 1973, ARCH INTERN MED, V132, P359, DOI 10.1001/archinte.132.3.359
   NAKASHIMA AK, 1987, J CLIN MICROBIOL, V25, P1014, DOI 10.1128/JCM.25.6.1014-1018.1987
   OKUDA T, 1981, J CLIN MICROBIOL, V20, P691
   PARMENT PA, 1992, CURR MICROBIOL, V25, P113, DOI 10.1007/BF01570969
   POOLE K, 1988, J BACTERIOL, V170, P5146, DOI 10.1128/jb.170.11.5146-5152.1988
   REPETTO G, 1993, ATLA-ALTERN LAB ANIM, V21, P501
   ROWE GE, 1994, METHOD ENZYMOL, V235, P637
   RUAN Y, 1990, ARCH MICROBIOL, V154, P221, DOI 10.1007/BF00248958
   RYDEN AC, 1968, ACTA CHEM SCAND, V22, P2803, DOI 10.3891/acta.chem.scand.22-2803
   Sekaninova G, 1995, Cent Eur J Public Health, V3, P80
   SERAFIM MB, 1994, REV MICROBIOL, V25, P220
   SIMBERKOFF MS, 1976, J LAB CLIN MED, V87, P206
   STEPHEN M, 1993, INDIAN J MED RES-A, V97, P202
   TAI SPS, 1990, MICROB PATHOGENESIS, V9, P267, DOI 10.1016/0882-4010(90)90015-I
   VOLKOWFERNANDEZ P, 1993, SALUD PUBLICA MEXICO, V35, P440
   WEINSTEIN DL, 1988, INFECT IMMUN, V56, P106, DOI 10.1128/IAI.56.1.106-111.1988
   YAMAKAWA K, 1994, J MED MICROBIOL, V41, P319, DOI 10.1099/00222615-41-5-319
   YAMAMOTO T, 1985, MICROBIOL IMMUNOL, V29, P677, DOI 10.1111/j.1348-0421.1985.tb00871.x
NR 42
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-8244
J9 FEMS IMMUNOL MED MIC
JI FEMS Immunol. Med. Microbiol.
PD DEC 31
PY 1996
VL 16
IS 3-4
BP 299
EP 307
DI 10.1016/S0928-8244(96)00097-1
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA WE313
UT WOS:A1996WE31300018
PM 9116649
OA Bronze
DA 2020-11-10
ER

PT J
AU FONSECA, BAL
   PINCUS, S
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
AF FONSECA, BAL
   PINCUS, S
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
TI RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEIN-PRM AND
   GLYCOPROTEIN-E INDUCE NEUTRALIZING ANTIBODIES IN MICE (VOL 12, PG 279,
   1994)
SO VACCINE
LA English
DT Correction, Addition
CR FONSECA BAL, 1994, VACCINE, V12, P279, DOI 10.1016/0264-410X(94)90206-2
NR 1
TC 3
Z9 3
U1 0
U2 0
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0264-410X
J9 VACCINE
JI Vaccine
PD APR
PY 1994
VL 12
IS 5
BP 480
EP 480
PG 1
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA NB397
UT WOS:A1994NB39700021
DA 2020-11-10
ER

PT J
AU FONSECA, BAL
   PINCUS, S
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
AF FONSECA, BAL
   PINCUS, S
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
TI RECOMBINANT VACCINIA VIRUSES CO-EXPRESSING DENGUE-1 GLYCOPROTEINS PRM
   AND E-INDUCE NEUTRALIZING ANTIBODIES IN MICE
SO VACCINE
LA English
DT Article
DE DENGUE; VACCINIA; RECOMBINANT; IMMUNOGENICITY
ID JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; NONSTRUCTURAL PROTEIN
   NS1; INTERFERON GAMMA-PRODUCTION; LETHAL JEV INFECTION;
   MONOCLONAL-ANTIBODIES; STRUCTURAL PROTEINS; PROTECTIVE IMMUNITY;
   MEMBRANE-PROTEINS; PASSIVE TRANSFER
AB Four recombinant vaccinia viruses expressing different portions of the dengue type I virus (DEN-I) genome (C-prM-E-NS1-NS2A-NS2B; prM-E; prM-E-NS1-NS2A-NS2B; or NS1-NS2A) were constructed in order to establish the most immunogenic configuration of DEN-1 proteins. Both recombinants producing prM and E in the absence of c induced the synthesis of extracellular forms of E in vitro. Mice inoculated with these two recombinants produced DEN-I neutralizing (NEUT) and haemagglutination inhibiting (HAI) antibodies. The other two recombinant vaccinia viruses, which did not induce the production of extracellular forms of E, did not induce E-specific immune responses. These results support our previous studies on the design of flavivirus-vaccinia vaccine candidates by showing the importance of co-expressing prM and E in order to induce the synthesis of extracellular E and to elicit NEUT and HAI antibodies.
C1 YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,YALE ARBOVIRUS RES UNIT,NEW HAVEN,CT 06510.
   VIROGENET CORP,TROY,NY 12180.
   US ARS,PLUM ISL ANIM DIS CTR,GREENPORT,NY 11944.
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 10987-17] Funding Source: Medline
CR Bhamarapravati N., 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P709
   BRAY M, 1991, VIROLOGY, V185, P505, DOI 10.1016/0042-6822(91)90809-P
   BRAY M, 1989, J VIROL, V63, P2853, DOI 10.1128/JVI.63.6.2853-2856.1989
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   DEUBEL V, 1988, J GEN VIROL, V69, P1921, DOI 10.1099/0022-1317-69-8-1921
   DEUBEL V, 1991, VIROLOGY, V180, P442, DOI 10.1016/0042-6822(91)90055-G
   EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2
   GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591
   GUO PX, 1989, J VIROL, V63, P4189, DOI 10.1128/JVI.63.10.4189-4198.1989
   HAHN YS, 1990, ARCH VIROL, V115, P251, DOI 10.1007/BF01310534
   HAISHI S, 1989, ACTA VIROL, V33, P497
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1981, AM J EPIDEMIOL, V114, P632, DOI 10.1093/oxfordjournals.aje.a113235
   HALSTEAD SB, 1977, J EXP MED, V146, P210
   HEINZ FX, 1983, VIROLOGY, V126, P525, DOI 10.1016/S0042-6822(83)80010-5
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   KONISHI E, 1992, VIROLOGY, V188, P714, DOI 10.1016/0042-6822(92)90526-U
   KONISHI E, 1991, VIROLOGY, V185, P401, DOI 10.1016/0042-6822(91)90788-D
   KURANE I, 1989, J EXP MED, V170, P763, DOI 10.1084/jem.170.3.763
   KURANE I, 1989, J CLIN INVEST, V83, P506, DOI 10.1172/JCI113911
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAI CJ, 1990, VACCINES 90, P119
   MANIATIS T, 1982, MOLCLONING
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   MASON PW, 1987, VIROLOGY, V161, P262, DOI 10.1016/0042-6822(87)90196-6
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   MATHEWS JH, 1984, J IMMUNOL, V132, P1533
   MATSUURA Y, 1989, VIROLOGY, V173, P674, DOI 10.1016/0042-6822(89)90580-1
   MCCOWN J, 1990, AM J TROP MED HYG, V42, P491, DOI 10.4269/ajtmh.1990.42.491
   MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991
   PANICALI D, 1982, P NATL ACAD SCI-BIOL, V79, P4927, DOI 10.1073/pnas.79.16.4927
   PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I
   PUTNAK JR, 1990, J GEN VIROL, V71, P1697, DOI 10.1099/0022-1317-71-8-1697
   PUTNAK R, 1991, AM J TROP MED HYG, V45, P159, DOI 10.4269/ajtmh.1991.45.159
   REPIK PM, 1983, AM J TROP MED HYG, V32, P577, DOI 10.4269/ajtmh.1983.32.577
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SATO T, 1993, VIROLOGY, V192, P483, DOI 10.1006/viro.1993.1064
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   YAMSHCHIKOV VF, 1993, VIROLOGY, V192, P38, DOI 10.1006/viro.1993.1006
   YASUDA A, 1990, J VIROL, V64, P2788, DOI 10.1128/JVI.64.6.2788-2795.1990
   YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417
   ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
NR 57
TC 85
Z9 89
U1 0
U2 2
PU BUTTERWORTH-HEINEMANN LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB
SN 0264-410X
J9 VACCINE
JI Vaccine
PD MAR
PY 1994
VL 12
IS 3
BP 279
EP 285
DI 10.1016/0264-410X(94)90206-2
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA MU369
UT WOS:A1994MU36900013
PM 8165861
DA 2020-11-10
ER

PT J
AU PINCUS, S
   MASON, PW
   KONISHI, E
   FONSECA, BAL
   SHOPE, RE
   RICE, CM
   PAOLETTI, E
AF PINCUS, S
   MASON, PW
   KONISHI, E
   FONSECA, BAL
   SHOPE, RE
   RICE, CM
   PAOLETTI, E
TI RECOMBINANT VACCINIA VIRUS PRODUCING THE PRM AND E-PROTEINS OF
   YELLOW-FEVER VIRUS PROTECTS MICE FROM LETHAL YELLOW-FEVER ENCEPHALITIS
SO VIROLOGY
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; DENGUE-2 VIRUS; STRUCTURAL
   GLYCOPROTEIN; NONSTRUCTURAL PROTEIN-NS1; PASSIVE TRANSFER; IMMUNIZATION;
   NS1; EXPRESSION; ENVELOPE
C1 VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180.
   USDA ARS,PLUM ISL ANIM DIS CTR,GREENPORT,NY 11944.
   WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110.
   YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,YALE ARBOVIRUS RES UNIT,NEW HAVEN,CT 06510.
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI 10987-17] Funding Source: Medline
CR BRANDT WE, 1988, J INFECT DIS, V157, P1105, DOI 10.1093/infdis/157.5.1105
   BRAY M, 1989, J VIROL, V63, P2853, DOI 10.1128/JVI.63.6.2853-2856.1989
   CANE PA, 1988, J GEN VIROL, V69, P1241, DOI 10.1099/0022-1317-69-6-1241
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DESPRES P, 1991, J GEN VIROL, V72, P1331, DOI 10.1099/0022-1317-72-6-1331
   DEUBEL V, 1988, J GEN VIROL, V69, P1921, DOI 10.1099/0022-1317-69-8-1921
   DEUBEL V, 1991, VIROLOGY, V180, P442, DOI 10.1016/0042-6822(91)90055-G
   EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591
   HAHN YS, 1990, ARCH VIROL, V115, P251, DOI 10.1007/BF01310534
   HAISHI S, 1989, ACTA VIROL, V33, P497
   HEINZ FX, 1983, VIROLOGY, V126, P525, DOI 10.1016/S0042-6822(83)80010-5
   HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   KONISHI E, 1991, VIROLOGY, V185, P401, DOI 10.1016/0042-6822(91)90788-D
   MANIATIS T, 1982, MOL CLONING
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   MATHEWS JH, 1984, J IMMUNOL, V132, P1533
   MATSUURA Y, 1989, VIROLOGY, V173, P674, DOI 10.1016/0042-6822(89)90580-1
   MCCOWN J, 1990, AM J TROP MED HYG, V42, P491, DOI 10.4269/ajtmh.1990.42.491
   MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991
   MONATH TP, 1986, TOGAVIRIDAE FLAVIVIR, P375
   PERKUS ME, 1989, J VIROL, V63, P3829, DOI 10.1128/JVI.63.9.3829-3836.1989
   POST PR, 1990, VIRUS RES, V18, P291
   PUTNAK JR, 1990, J GEN VIROL, V71, P1697, DOI 10.1099/0022-1317-71-8-1697
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RICE CM, 1988, MODERN TRENDS VIROLO, P83
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   SHIU SYW, 1991, J GEN VIROL, V72, P1451, DOI 10.1099/0022-1317-72-6-1451
   SHOPE RE, 1980, TOGAVIRUSES BIOL STR, P47
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   YASUDA A, 1990, J VIROL, V64, P2788, DOI 10.1128/JVI.64.6.2788-2795.1990
   YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417
   ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
NR 46
TC 94
Z9 98
U1 0
U2 1
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAR
PY 1992
VL 187
IS 1
BP 290
EP 297
DI 10.1016/0042-6822(92)90317-I
PG 8
WC Virology
SC Virology
GA HD628
UT WOS:A1992HD62800029
PM 1736531
DA 2020-11-10
ER

PT J
AU KONISHI, E
   PINCUS, S
   FONSECA, BAL
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
AF KONISHI, E
   PINCUS, S
   FONSECA, BAL
   SHOPE, RE
   PAOLETTI, E
   MASON, PW
TI COMPARISON OF PROTECTIVE IMMUNITY ELICITED BY RECOMBINANT VACCINIA
   VIRUSES THAT SYNTHESIZE-E OR NS1 OF JAPANESE ENCEPHALITIS-VIRUS
SO VIROLOGY
LA English
DT Article
ID NONSTRUCTURAL PROTEIN NS1; FLAVIVIRUS GENOME ORGANIZATION; LETHAL DENGUE
   INFECTION; MONOCLONAL-ANTIBODIES; YELLOW-FEVER; STRUCTURAL PROTEINS;
   ESCHERICHIA-COLI; E-GLYCOPROTEIN; MOUSE NEUROVIRULENCE; PASSIVE TRANSFER
C1 VIROGENET CORP,465 JORDAN RD,RENSSELAER TECHNOL PK,TROY,NY 12180.
   YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,YALE ARBOVIRUS RES UNIT,NEW HAVEN,CT 06510.
   USDA ARS,PLUM ISL ANIM DIS CTR,GREENPORT,NY 11944.
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI10987-17] Funding Source: Medline
CR BRAY M, 1989, J VIROL, V63, P2853, DOI 10.1128/JVI.63.6.2853-2856.1989
   CANE PA, 1988, J GEN VIROL, V69, P1241, DOI 10.1099/0022-1317-69-6-1241
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   DALESSIO JM, 1988, NUCLEIC ACIDS RES, V16, P1999
   DEUBEL V, 1988, J GEN VIROL, V69, P1921, DOI 10.1099/0022-1317-69-8-1921
   DEUBEL V, 1991, VIROLOGY, V180, P442, DOI 10.1016/0042-6822(91)90055-G
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990
   GOULD EA, 1986, J GEN VIROL, V67, P591, DOI 10.1099/0022-1317-67-3-591
   GUO PX, 1989, J VIROL, V63, P4189, DOI 10.1128/JVI.63.10.4189-4198.1989
   HAHN YS, 1990, ARCH VIROL, V115, P251, DOI 10.1007/BF01310534
   HAISHI S, 1989, ACTA VIROL, V33, P497
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HEINZ FX, 1983, VIROLOGY, V126, P525, DOI 10.1016/S0042-6822(83)80010-5
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   HUANG CH, 1982, ADV VIRUS RES, V27, P71, DOI 10.1016/S0065-3527(08)60433-9
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427
   KAUFMAN BM, 1989, AM J TROP MED HYG, V41, P576, DOI 10.4269/ajtmh.1989.41.576
   KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606
   MANDECKI W, 1986, P NATL ACAD SCI USA, V83, P7177, DOI 10.1073/pnas.83.19.7177
   MANIATIS T, 1982, MOL CLONING
   MASON PW, 1991, VIROLOGY, V180, P294, DOI 10.1016/0042-6822(91)90034-9
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   MASON PW, 1987, VIROLOGY, V158, P361, DOI 10.1016/0042-6822(87)90208-X
   MATHEWS JH, 1984, J IMMUNOL, V132, P1533
   MATSUURA Y, 1989, VIROLOGY, V173, P674, DOI 10.1016/0042-6822(89)90580-1
   MCADA PC, 1987, VIROLOGY, V158, P348, DOI 10.1016/0042-6822(87)90207-8
   MCCOWN J, 1990, AM J TROP MED HYG, V42, P491, DOI 10.4269/ajtmh.1990.42.491
   MEN R, 1991, J VIROL, V65, P1400, DOI 10.1128/JVI.65.3.1400-1407.1991
   MONATH TP, 1986, TOGAVIRIDAE FLAVIVIR, P375
   OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161
   PANICALI D, 1982, P NATL ACAD SCI-BIOL, V79, P4927, DOI 10.1073/pnas.79.16.4927
   PUTNAK JR, 1990, J GEN VIROL, V71, P1697, DOI 10.1099/0022-1317-71-8-1697
   REPIK PM, 1983, AM J TROP MED HYG, V32, P577, DOI 10.4269/ajtmh.1983.32.577
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853
   SCHLESINGER JJ, 1985, J IMMUNOL, V135, P2805
   SCHLESINGER JJ, 1986, J VIROL, V60, P1153, DOI 10.1128/JVI.60.3.1153-1155.1986
   SHOPE RE, 1980, TOGAVIRUSES BIOL STR, P47
   YASUDA A, 1990, J VIROL, V64, P2788, DOI 10.1128/JVI.64.6.2788-2795.1990
   YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417
   ZHANG YM, 1988, J VIROL, V62, P3027, DOI 10.1128/JVI.62.8.3027-3031.1988
   ZHAO B, 1987, J VIROL, V61, P4019, DOI 10.1128/JVI.61.12.4019-4022.1987
NR 45
TC 99
Z9 105
U1 0
U2 4
PU ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495
SN 0042-6822
J9 VIROLOGY
JI Virology
PD NOV
PY 1991
VL 185
IS 1
BP 401
EP 410
DI 10.1016/0042-6822(91)90788-D
PG 10
WC Virology
SC Virology
GA GJ980
UT WOS:A1991GJ98000043
PM 1833876
DA 2020-11-10
ER

PT J
AU FONSECA, BAL
   KHOSHNOOD, K
   SHOPE, RE
   MASON, PW
AF FONSECA, BAL
   KHOSHNOOD, K
   SHOPE, RE
   MASON, PW
TI FLAVIVIRUS TYPE-SPECIFIC ANTIGENS PRODUCED FROM FUSIONS OF A PORTION OF
   THE E-PROTEIN GENE WITH THE ESCHERICHIA-COLI TRPE GENE
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PARTIAL NUCLEOTIDE-SEQUENCE; ENCEPHALITIS-VIRUS GENOME; YELLOW-FEVER
   VIRUS; STRUCTURAL PROTEINS; DENGUE; RNA; DNA; IDENTIFICATION;
   AMPLIFICATION; ANTIBODIES
AB Based on previous data showing that JEV and DEN-1 fusion proteins can be used as antigens, we engineered analogous fusion proteins for the same regions of the E proteins of DEN-2, DEN-3, and DEN-4, using the polymerase chain reaction. The resulting fusion proteins were tested in a modified ELISA for their reactivity with mouse immune ascitic fluids (MIAF) generated against 10 different flaviviruses. The results showed that these recombinant antigens could be used as type-specific immunological reagents, and suggest that these antigens could ser-ve as the basis for rapid, safe, and inexpensive flavivirus serosurveys.
C1 YALE UNIV, SCH MED, DEPT EPIDEMIOL & PUBL HLTH, YALE ARBOVIRUS RES UNIT, NEW HAVEN, CT 06510 USA.
   INST ADOLFO LUTZ REGISTRO, DEPT VIROL, SECAO ARBOVIRUS, SAO PAULO, BRAZIL.
   USDA ARS, PLUM ISL ANIM DIS CTR, GREENPORT, NY 11944 USA.
RI Fonseca, Benedito/F-3252-2012
OI Fonseca, Benedito/0000-0003-3159-5687
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [AI-10987-17] Funding Source: Medline
CR BRANDT WE, 1967, AM J TROP MED HYG, V16, P339, DOI 10.4269/ajtmh.1967.16.339
   CABRADILLA CD, 1986, BIO-TECHNOL, V4, P128, DOI 10.1038/nbt0286-128
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   COIA G, 1988, J GEN VIROL, V69, P1, DOI 10.1099/0022-1317-69-1-1
   DALGARNO L, 1986, J MOL BIOL, V187, P309, DOI 10.1016/0022-2836(86)90435-3
   DOWBENKO DJ, 1985, P NATL ACAD SCI USA, V82, P7748, DOI 10.1073/pnas.82.22.7748
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   GRUENBERG A, 1988, J GEN VIROL, V69, P1391, DOI 10.1099/0022-1317-69-6-1391
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1982, PROG ALLERGY, V31, P301
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   KOERNER TJ, 1991, METHOD ENZYMOL, V194, P477
   MASON PW, 1987, VIROLOGY, V161, P262, DOI 10.1016/0042-6822(87)90196-6
   MASON PW, 1989, J GEN VIROL, V70, P2037, DOI 10.1099/0022-1317-70-8-2037
   MASON PW, 1990, J GEN VIROL, V71, P2107, DOI 10.1099/0022-1317-71-9-2107
   MCADA PC, 1987, VIROLOGY, V158, P348, DOI 10.1016/0042-6822(87)90207-8
   MONATH TP, 1986, TOGAVIRIDAE FLAVIVIR, P375
   OHARA O, 1989, P NATL ACAD SCI USA, V86, P5673, DOI 10.1073/pnas.86.15.5673
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   RUSSELL PK, 1967, J IMMUNOL, V99, P291
   SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   SHOPE RE, 1980, TOGAVIRUSES BIOL STR, P47
   TESH RB, 1979, AM J TROP MED HYG, V28, P1053, DOI 10.4269/ajtmh.1979.28.1053
   TRENT DW, 1987, VIROLOGY, V156, P293, DOI 10.1016/0042-6822(87)90409-0
   Voller A., 1986, MANUAL CLIN LABORATO, P99
   WENGLER G, 1985, VIROLOGY, V147, P264, DOI 10.1016/0042-6822(85)90129-1
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   ZHAO B, 1986, VIROLOGY, V155, P77, DOI 10.1016/0042-6822(86)90169-8
NR 31
TC 30
Z9 34
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 1991
VL 44
IS 5
BP 500
EP 508
DI 10.4269/ajtmh.1991.44.500
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA FW270
UT WOS:A1991FW27000006
PM 1648310
DA 2020-11-10
ER

EF